FONAR (FONR) 10-K29 Sep 142014 FY Annual reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
Document and Entity Information (USD $)	Jun. 30, 2014	Sep. 05, 2014
Document And Entity Information	'	'
Entity Registrant Name	'Fonar Corporation	'
Entity Central Index Key	'0000355019	'
Document Type	'10-K	'
Document Period End Date	30-Jun-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--06-30	'
Is Entity a Well-known Seasoned Issuer?	'No	'
Is Entity a Voluntary Filer?	'No	'
Is Entity's Reporting Status Current?	'Yes	'
Entity Filer Category	'Accelerated Filer	'
Entity Public Float	'	$125,000,000
Entity Common Stock, Shares Outstanding	'	6,050,840
Document Fiscal Period Focus	'FY	'
Document Fiscal Year Focus	'2014	'

Balance_Sheets

Balance Sheets (USD $)	Jun. 30, 2014	Jun. 30, 2013
Current Assets:	'	'
Cash and cash equivalents	$9,951,736	$7,870,727
Accounts receivable - net of allowances for doubtful accounts of $257,362 at June 30, 2014 and 2013	4,450,125	4,443,595
Medical receivable -net of allowances for doubtful accounts of $12,917,751 and $2,584,669 at June 30, 2014 and 2013, respectively	8,807,856	8,126,476
Management and other fees receivable - net of allowances for doubtful accounts of $10,901,619 and $9,095,320 at June 30, 2014 and 2013, respectively	11,970,388	11,465,913
Management and other fees receivable - related medical practices - net of allowances for doubtful accounts of $403,047 at June 30, 2014 and 2013	3,426,982	2,381,664
Costs and estimated earnings in excess of billings on uncompleted contracts	759,809	445,742
Inventories	2,443,536	2,077,088
Prepaid expenses and other current assets	1,011,358	1,054,551
Total Current Assets	42,821,790	37,865,756
Deferred Income Tax Asset	5,740,287	2,935,750
Property and Equipment - Net	15,029,729	17,524,494
Goodwill	1,767,098	1,767,098
Other Intangible Assets - Net	10,508,843	11,904,248
Other Assets	922,096	1,153,304
Total Assets	76,789,843	73,150,650
Current Liabilities:	'	'
Current portion of long-term debt and capital leases	2,890,816	2,885,769
Accounts payable	2,481,997	2,752,479
Other current liabilities	9,024,033	8,494,361
Unearned revenue on service contracts	4,730,962	4,965,415
Customer advances	1,926,813	1,857,870
Billings in excess of costs and estimated earnings on uncompleted contracts	142,217	142,217
Income tax payable	'	19,501
Total Current Liabilities	21,196,838	21,117,612
Long-Term Liabilities:	'	'
Deferred Income Tax Liability	583,990	461,858
Due to Related Medical Practices	234,581	230,626
Long-Term Debt and Capital Leases, Less Current Portion	8,481,830	12,887,005
Other Liabilities	386,012	654,273
Total Long-Term Liabilities	9,686,413	14,233,762
Total Liabilities	30,883,251	35,351,374
Stockholders' Equity:	'	'
Paid-in capital in excess of par value	175,284,437	174,499,020
Accumulated deficit	-149,259,286	-159,655,416
Notes receivable from employee stockholders	-38,828	-54,820
Treasury stock, at cost - 11,643 shares of common stock at June 30, 2014 and 2013	-675,390	-675,390
Total Fonar Corporation's Stockholders' Equity	25,311,608	14,114,061
Noncontrolling interests	20,594,984	23,685,215
Total Stockholders' Equity	45,906,592	37,799,276
Total Liabilities and Stockholders' Equity	76,789,843	73,150,650
Class A Non-Voting Preferred	'	'
Stockholders' Equity:	'	'
Preferred Stock Value	31	31
Class A Non-Voting Preferred Stock	'	'
Stockholders' Equity:	'	'
Preferred Stock Value	'	'
Common Stock	'	'
Stockholders' Equity:	'	'
Common Stock Value	606	598
Class B Members	'	'
Stockholders' Equity:	'	'
Common Stock Value	'	'
Class C Common	'	'
Stockholders' Equity:	'	'
Common Stock Value	$38	$38

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (USD $)	Jun. 30, 2014	Jun. 30, 2013
Class A Non-Voting Preferred	'	'
Preferred Stock, Par Value	$0.00	$0.00
Preferred Stock, Authorized	453,000	453,000
Preferred Stock, Issued	313,438	313,438
Preferred Stock, Outstanding	313,438	313,438
Class A Non-Voting Preferred Stock	'	'
Preferred Stock, Par Value	$0.00	$0.00
Preferred Stock, Authorized	567,000	567,000
Preferred Stock, Issued	'	'
Preferred Stock, Outstanding	'	'
Common Stock	'	'
Common Stock, Par Value	$0.00	$0.00
Common Stock, Authorized	8,500,000	8,500,000
Common Stock, Issued	6,057,483	5,980,775
Common Stock, Outstanding	6,045,840	5,969,132
Class B Members	'	'
Common Stock, Par Value	$0.00	$0.00
Common Stock, Authorized	227,000	227,000
Common Stock, Issued	146	146
Common Stock, Outstanding	146	146
Class C Common	'	'
Common Stock, Par Value	$0.00	$0.00
Common Stock, Authorized	567,000	567,000
Common Stock, Issued	382,513	382,513
Common Stock, Outstanding	382,513	382,513

Statements_of_Operations

Statements of Operations (USD $)	12 Months Ended
Statements of Operations (USD $)	Jun. 30, 2014	Jun. 30, 2013
Revenues	'	'
Product sales - net	$1,877,932	$3,939,140
Service and repair fees - net	10,082,631	10,841,935
Service and repair fees - related parties - net	110,000	110,000
Patient revenue - net of contractual allowances and discounts	24,307,192	7,481,865
Provision for bad debts for patient fee	-10,333,082	-2,584,669
Management and other fees - net	34,839,969	21,493,599
Management and other fees - related medical practices - net	7,620,835	7,859,944
Total Revenues - Net	68,505,477	49,141,814
Costs and Expenses	'	'
Costs related to product sales	1,067,120	3,656,635
Costs related to service and repair fees	2,496,985	3,213,420
Costs related to service and repair fees -related parties	27,242	32,603
Costs related to patient fee revenue	7,670,484	2,704,758
Costs related to management and other fees	20,851,065	12,998,243
Costs related to management and other fees - related medical practices	5,134,553	3,515,706
Research and development	1,760,821	1,438,560
Selling, general and administrative, inclusive of compensatory element of stock issuances of $223,000 and $415,021 for the years ended June 30, 2014 and 2013, respectively	15,388,239	12,501,621
Provision for bad debts	1,806,299	1,544,521
Total Costs and Expenses	56,202,808	41,606,067
Income from Operations	12,302,669	7,535,747
Other Income and (Expenses):	'	'
Interest expense	-884,541	-500,362
Investment income	238,928	217,598
Other (expense) income - net	-608,599	725,488
Income before benefit (provision) for income taxes and noncontrolling interests	11,048,457	7,978,471
Benefit for Income Taxes	2,348,312	2,277,891
Net Income	13,396,769	10,256,362
Net Income - Noncontrolling Interests	-3,000,639	-1,577,820
Net Income - Controlling Interests	10,396,130	8,678,542
Weighted Average Basic Shares Outstanding	6,009,822	5,933,318
Weighted Average Diluted Shares Outstanding	6,137,326	6,060,822
Common Stock	'	'
Other Income and (Expenses):	'	'
Net Income - Controlling Interests	9,720,030	8,107,367
Basic Net Income Per Common Share Available to Common Stockholders	$1.62	$1.37
Diluted Net Income Per Common Share Available to Common Stockholders	$1.58	$1.34
Weighted Average Basic Shares Outstanding	6,009,822	5,933,318
Weighted Average Diluted Shares Outstanding	6,137,326	6,060,822
Class A Non Voting Preferred Stock	'	'
Other Income and (Expenses):	'	'
Net Income - Controlling Interests	503,911	425,708
Class C Common	'	'
Other Income and (Expenses):	'	'
Net Income - Controlling Interests	$172,189	$145,467
Basic Net Income Per Common Share Available to Common Stockholders	$0.45	$0.38
Diluted Net Income Per Common Share Available to Common Stockholders	$0.45	$0.38
Basic and Diluted Income Per Share - Common C	$0.45	$0.38
Weighted Average Basic Shares Outstanding	382,513	382,513
Weighted Average Diluted Shares Outstanding	382,513	382,513

Statements_of_Operations_Paren

Statements of Operations (Parenthetical) (USD $)	12 Months Ended
Statements of Operations (Parenthetical) (USD $)	Jun. 30, 2014	Jun. 30, 2013
Income Statement [Abstract]	'	'
compensatory element of stock issuances	$223,000	$415,021

Shareholders_Equity_and_Compre

Shareholders Equity and Comprehensive Income (USD $)	Class A Non-Voting Preferred	Common Stock	Class C Common	Paid-in Capital in Excess of Par Value	Treasury Stock	Notes Receivable	Accumulated Deficit	Noncontrolling Interest	Total
Balance - Beginning, Value at Jun. 30, 2012	$31	$590	$38	$174,084,007	($675,390)	($70,813)	($168,333,958)	$6,096,560	$11,101,065
Balance - Beginning, Shares at Jun. 30, 2012	'	5,901,262	'	'	'	'	'	'	'
Net Income	'	'	'	'	'	'	8,678,542	1,577,820	10,256,362
Stock issued to employees under stock bonus plans, Shares	'	67,870	'	'	'	'	'	'	'
Stock issued to employees under stock bonus plans, Value	'	8	'	415,013	'	'	'	'	415,021
Issuance of stock for goods and services, Shares	'	'	'	'	'	'	'	'	'
Issuance of stock for goods and services, Value	'	'	'	'	'	'	'	'	'
Payments on notes receivable from employee stockholders	'	'	'	'	'	15,993	'	'	15,993
Buyout of noncontrolling interests	'	'	'	'	'	'	'	-564,315	564,315
Stock option exercised, Shares	'	'	'	'	'	'	'	'	'
Stock option exercised, Value	'	'	'	'	'	'	'	'	'
Redemption of noncontrolling interests	'	'	'	'	'	'	'	-1,424,900	-1,424,900
Distributions to noncontrolling interests	'	'	'	'	'	'	'	-1,799,950	-1,799,950
Proceeds from noncontrolling interest	'	'	'	'	'	'	'	19,800,000	19,800,000
Balance - Ending, Value at Jun. 30, 2013	31	598	38	174,499,020	-675,390	-54,820	-159,655,416	23,685,215	37,799,276
Balance - Ending, Shares at Jun. 30, 2013	'	5,969,132	'	'	'	'	'	'	'
Net Income	'	'	'	'	'	'	10,396,130	3,000,639	13,396,769
Stock issued to employees under stock bonus plans, Shares	'	21,443	'	'	'	'	'	'	'
Stock issued to employees under stock bonus plans, Value	'	2	'	222,998	'	'	'	'	223,000
Issuance of stock for goods and services, Shares	'	45,265	'	'	'	'	'	'	'
Issuance of stock for goods and services, Value	'	5	'	531,820	'	'	'	'	'
Payments on notes receivable from employee stockholders	'	'	'	'	'	15,992	'	'	'
Buyout of noncontrolling interests	'	'	'	'	'	'	'	'	'
Stock option exercised, Shares	'	10,000	'	'	'	'	'	'	'
Stock option exercised, Value	'	1	'	30,599	'	'	'	'	30,600
Redemption of noncontrolling interests	'	'	'	'	'	'	'	-1,125,100	'
Distributions to noncontrolling interests	'	'	'	'	'	'	'	-4,965,770	-4,965,770
Proceeds from noncontrolling interest	'	'	'	'	'	'	'	'	'
Balance - Ending, Value at Jun. 30, 2014	$31	$606	$38	$175,284,437	($675,390)	($38,828)	($149,259,286)	$20,594,984	$45,906,592
Balance - Ending, Shares at Jun. 30, 2014	'	6,045,840	'	'	'	'	'	'	'

Statements_of_Cash_Flows

Statements of Cash Flows (USD $)	12 Months Ended
Statements of Cash Flows (USD $)	Jun. 30, 2014	Jun. 30, 2013
Statement of Cash Flows [Abstract]	'	'
Net Income	$13,396,769	$10,256,362
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	3,817,205	2,421,177
Abandoned patents or software written off	250,523	66,619
Provision for bad debts	1,806,299	1,544,521
Deferred income tax benefit	-2,682,405	-2,473,892
Gain on sale of equipment	'	-557,473
Loss on disposition of equipment	657,350	'
Gain on litigation settlement	'	-755,500
Impairment on management agreement	'	357,500
Compensatory element of stock issuances	223,000	415,021
Stock issued for costs and expenses	531,825	'
(Increase) decrease in operating assets, net:	'	'
Accounts, management fee and medical receivable(s)	-4,044,002	-3,717,440
Notes receivable	95,623	120,976
Costs and estimated earnings in excess of Billings on uncompleted contracts	-314,067	682,854
Inventories	-366,448	117,861
Prepaid expenses and other current assets	46,967	-698,284
Other assets	131,811	-204,037
Increase (decrease) in operating liabilities, net:	'	'
Accounts payable	-270,482	628,033
Other current liabilities	295,219	-414,402
Customer advances	68,943	-567,914
Billings in excess of costs and estimated earnings on uncompleted contracts	'	142,217
Other liabilities	-268,261	253,559
Due to related medical practices	3,955	1,885
Income tax payable	-19,501	-80,499
NET CASH PROVIDED BY OPERATING ACTIVITIES	13,360,323	7,539,144
Cash Flows from Investing Activities:	'	'
Purchases of property and equipment	-620,697	-1,135,382
Cost of acquisition	'	-40,000,000
Cost of patents	-214,211	-159,907
NET CASH USED IN INVESTING ACTIVITIES	-834,908	-41,295,289
Cash Flows from Financing Activities	'	'
Proceeds from debt	'	14,689,646
Proceeds from sale of equipment	'	700,000
Repayment of borrowings and capital lease obligations	-4,400,128	-1,821,617
Repayment of notes receivable from employee stockholders	15,992	15,993
Stock option exercised	30,600	'
Distributions to noncontrolling interests	-4,965,770	-1,799,950
Redemption of noncontroling Interests	-4,965,770	-1,799,950
Buyout of noncontroling Interest	'	564,315
Proceeds from noncontrolling interest	'	19,800,000
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES	-10,444,406	29,594,857
Net Increase in Cash and Cash Equivalents	2,081,009	-4,161,288
Cash and Cash Equivalents Beginning of Year	7,870,727	12,032,015
Cash and Cash Equivalents - End of Year	$9,951,736	$7,870,727

NOTE_1_DESCRIPTION_OF_BUSINESS

NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES	12 Months Ended
	Jun. 30, 2014
Accounting Policies [Abstract]	'
NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES	'
	NOTE 1 - DESCRIPTION OF BUSINESS AND LIQUIDITY AND CAPITAL RESOURCES

	Description of Business

	FONAR Corporation (the “Company” or “FONAR”) is a Delaware corporation, which was incorporated on July 17, 1978. FONAR is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging ("MRI") for the detection and diagnosis of human diseases. In addition to deriving revenues from the direct sale of MRI equipment, revenue is also generated from our installed-base of customers through our service and upgrade programs.

	FONAR, through its wholly-owned subsidiary Health Management Corporation of America ("HMCA") provides comprehensive management services to diagnostic imaging facilities. The services provided by the Company include development, administration, leasing of office space, facilities and medical equipment, provision of supplies, staffing and supervision of non-medical personnel, legal services, accounting, billing and collection and the development and implementation of practice growth and marketing strategies.

	On March 5, 2013, the Company acquired a majority interest in a newly formed limited liability company, Health Diagnostics Management LLC (HDM), a business managing 12 Stand-Up MRI centers and 2 other scanning centers located in Florida and New York for a total cost of $40 million. HDM has a perpetual existence. See Note 9.

	During May 2011, HMCA contributed all of its assets together with its liabilities to a newly formed limited liability company, Imperial Management Services, LLC (“Imperial”), which has a perpetual existence. As of June 30, 2014, Imperial manages 11 diagnostic imaging facilities which are located in the states of New York and Florida.

NOTE_2_SUMMARY_OF_SIGNIFICANT_

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Jun. 30, 2014

Accounting Policies [Abstract]

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation

The consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries and partnerships. The operating activities of subsidiaries are included in the accompanying consolidated statements from the date of acquisition. All significant intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. The most significant estimates relate to receivable allowances, intangible assets, income taxes and related tax asset valuation allowances, useful lives of property and equipment, contingencies, revenue recognition and the assessment of litigation. In addition, healthcare industry reforms and reimbursement practices will continue to impact the Company's operations and the determination of contractual and other allowance estimates. Actual results could differ from those estimates.

Inventories

Inventories consist of purchased parts, components and supplies, as well as work-in-process, and are stated at the lower of cost, determined on the first-in, first-out method, or market.

Property and Equipment

Property and equipment procured in the normal course of business is stated at cost. Property and equipment purchased in connection with an acquisition is stated at its estimated fair value, generally based on an appraisal. Property and equipment is being depreciated for financial accounting purposes using the straight-line method over their estimated useful lives. Leasehold improvements are being amortized over the shorter of the useful life or the remaining lease term. Upon retirement or other disposition of these assets, the cost and related accumulated depreciation of these assets are removed from the accounts and the resulting gains or losses are reflected in the results of operations. Expenditures for maintenance and repairs are charged to operations. Renewals and betterments are capitalized. Maintenance and repair expenses totaled approximately $1,037,000 and $598,000 for the years ended June 30, 2014 and 2013, respectively. The estimated useful lives in years are generally as follows:

Diagnostic equipment under capital lease

2.5

Diagnostic equipment

5–13

Research, development and demonstration equipment

7-Mar

Machinery and equipment

7-Feb

Furniture and fixtures

9-Mar

Leasehold improvements

2–10

Building

Long-Lived Assets

The Company periodically assesses the recoverability of long-lived assets, including property and equipment and intangibles, other than goodwill, when there are indications of potential impairment, based on estimates of undiscounted future cash flows. The amount of impairment is calculated by comparing anticipated discounted future cash flows with the carrying value of the related asset. In performing this analysis, management considers such factors as current results, trends, and future prospects, in addition to other economic factors.

Deferred Rent

Rent expense is recorded on the straight-line method based on the total minimum rent payments required over the term of the lease. The cumulative difference between the lease expense recorded under this method and the contractual lease payment terms is recorded as deferred rent.

Other Intangible Assets

1) Capitalized Software Development Costs

Capitalization of software development costs begins upon the establishment of technological feasibility. Technological feasibility for the Company’s computer software is generally based upon achievement of a detail program design free of high risk development issues and the completion of research and development on the product hardware in which it is to be used. The establishment of technological feasibility and the ongoing assessment of recoverability of capitalized computer software development costs require considerable judgment by management with respect to certain external factors, including, but not limited to, technological feasibility, anticipated future gross revenue, estimated economic life and changes in software and hardware technology. Prior to reaching technological feasibility those costs are expensed as incurred and included in research and development.

Amortization of capitalized software development costs commences when the related products become available for general release to customers. Amortization is provided on a product by product basis. The annual amortization is the greater of the amount computed using (a) the ratio that current gross revenue for a product bears to the total of current and anticipated future gross revenue for that product, or (b) the straight-line method over the remaining estimated economic life of the product.

The Company periodically performs reviews of the recoverability of such capitalized software development costs. At the time a determination is made that capitalized amounts are not recoverable, based on the estimated cash flows to be generated from the applicable software, any remaining capitalized amounts are written off.

2) Patents and Copyrights

Amortization is calculated on the straight-line basis over a period ranging from 15 to 17 years.

3) Management Agreement

The management agreement was being amortized on the straight line basis over the length of the agreement (15 years). For the year ended June 30, 2013, the Company recorded an impairment of $357,500 as a result of the closing of a scanning center in New York.

4) Non-Competition Agreements

The non-competition agreements are being amortized on the straight line basis over the length of the agreement (7 years).

5) Customer Relationships

Amortization is calculated on the straight line basis over 20 years.

Goodwill

Generally accepted accounting principles in the United States require the Company to perform a goodwill impairment test annually and more frequently when negative conditions or a triggering event arises. Impairment of goodwill is tested at the reporting unit level by comparing the reporting unit’s carrying amount, including goodwill to the fair value of the reporting unit. If the carrying amount of the reporting unit exceeds its fair value, goodwill is considered potentially impaired and a second step is performed to measure the amount of impairment loss, if any.

Acquired assets and assumed liabilities

Pursuant to ASC No. 805-10-25, if the initial accounting for a business combination is incomplete by the end of the reporting period in which the combination occurs, but during the allowed measurement period not to exceed one year from the acquisition date, the Company retrospectively adjusts the provisional amounts recognized at the acquisition date by means of adjusting the amount recognized for goodwill.

Revenue Recognition

Revenue on sales contracts for scanners, included in “product sales” in the accompanying consolidated statements of operations, is recognized under the percentage-of-completion method in accordance with FASB ASC 605-35, “Revenue Recognition – Construction-Type and Production-Type Contracts”. The Company manufactures its scanners under specific contracts that provide for progress payments. Production and installation take approximately three to six months.

Revenue on scanner service contracts is recognized on the straight-line method over the related contract period, usually one year.

Revenue from sales of other items is recognized upon shipment.

Revenue under management contracts is recognized based upon contractual agreements for management services rendered by the Company primarily under various long-term agreements with various medical providers (the "PCs"). As of June 30, 2014, the Company has twenty management agreements of which three are with PC’s owned by Raymond V. Damadian, M.D., President and Chairman of the Board of FONAR (“the Related medical practices”) and seventeen are with PC’s, which are all located in the state of New York (“the New York PC’s”), owned by two unrelated radiologists. The contractual fees for services rendered to the PCs consists of fixed monthly fees per diagnostic imaging facility ranging from approximately $35,000 to $242,000. All fees are re-negotiable at the anniversary of the agreements and each year thereafter. Revenue under lease contracts is recognized based upon contractual agreements for the leasing of medical equipment primarily under long term contracts to various unrelated PC’s. The lease fees for the medical equipment consist of fixed monthly fees ranging from $2,000 to $19,000. All fees are re-negotiable at the anniversary of the agreements and each year thereafter.

Patient fee revenue, net of contractual allowance and discounts, consist of net patient fees received from insurance companies, third party payors (including federal and state agencies under Medicare and Medicaid programs), hospitals and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments and discounts. Patient fee revenue is recorded in the period in which services are provided.

The Company’s patient fee revenue, net of contractual allowances and discounts less the provision for bad debts for the years ended June 30, 2014 and 2013 are summarized in the following table.

For the Year Ended June 30,

2014

2013

Commercial Insurance/ Managed Care

4,217,088

1,360,536

Medicare/Medicaid

1,443,020

541,602

Workers' Compensation/Personal Injury

13,369,956

3,597,416

Other

5,277,128

1,982,311

Patient Fee Revenue, net of contractual allowances and discounts

24,307,192

7,481,865

Provision for Bad Debts

(10,333,082

)

(2,584,669

)

Net Patient Fee Revenue

13,974,110

4,897,196

Allowance for Doubtful Accounts – Patient Fee

The Company provides for medical receivables that could become uncollectible by establishing an allowance for doubtful accounts in order to adjust medical receivables to estimated net realizable value. In evaluating the collectability of medical receivables, the Company considers a number of factors, including the age of the account, historical collection experiences, payor type, current economic conditions and other relevant factors. There are various factors that impact collection trends, such as payor mix, changes in the economy, increase burden on copayments to be made by patients with insurance and business practices related to collection efforts. These factors continuously change and can have an impact on collection trends and the estimation process.

Research and Development Costs

Research and development costs are charged to expense as incurred. The costs of materials and equipment that are acquired or constructed for research and development activities, and have alternative future uses (either in research and development, marketing or production), are classified as property and equipment and depreciated over their estimated useful lives.

Advertising Costs

Advertising costs are expensed as incurred. Advertising expense approximated $889,000 and $835,000 for the years ended June 30, 2014 and 2013, respectively.

Shipping Costs

The Company’s shipping and handling costs are included in revenue from product sales and the related expense included in costs related to product sales is $1,885 and $5,838 for the years ended June 30, 2014 and 2013, respectively.

Income Taxes

Deferred tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and tax basis of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.

Customer Advances

Cash advances and progress payments received on sales orders are reflected as customer advances until such time as revenue recognition begins.

Earnings Per Share

Basic earnings per share (“EPS”) is computed based upon the weighted average number of shares of common stock and stock equivalents outstanding, net of common stock. In accordance with ASC topic 260-10, “Participating Securities and the Two-Class Method”, the Company used the Two-Class method for calculating basic earnings per share and applied the if converted method in calculating diluted earnings per share for the years ended June 30, 2014 and June 30, 2013.

Diluted EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average market price of common shares outstanding during the period. For both the year ended June 30, 2014 and June 30, 2013, diluted EPS for common shareholders includes 127,504 shares upon conversion of Class C Common.

30-Jun-14

Basic

Total

Common Stock

Class C Common Stock

Numerator:

Net income Available to common stockholders

10,396,130

9,720,030

172,189

Denominator:

Weighted average shares outstanding

6,009,822

382,513

Basic income per common share

1.73

1.62

0.45

Diluted

Denominator:

Weighted average shares outstanding

6,009,822

382,513

Class C Common Stock

127,504

—

Total Denominator for diluted earnings per share

6,137,326

382,513

Diluted income per common share

1.58

0.45

30-Jun-13

Basic

Total

Common Stock

Class C Common Stock

Numerator:

Net income Available to common stockholders

8,678,542

8,107,367

145,467

Denominator:

Weighted average shares outstanding

5,933,318

382,513

Basic income per common share

1.46

1.37

0.38

Diluted

Denominator:

Weighted average shares outstanding

5,933,318

382,513

Class C Common Stock

127,504

—

Total Denominator for diluted earnings per share

6,060,822

382,513

Diluted income per common share

1.34

0.38

Cash and Cash Equivalents

The Company considers all short-term highly liquid investments with a maturity of three months or less when purchased to be cash equivalents.

Concentration of Credit Risk

Cash: The Company maintains its cash and cash equivalents with various financial institutions, which exceed federally insured limits throughout the year. At June 30, 2014, the Company had cash on deposit of approximately $8,035,000 in excess of federally insured limits of $250,000.

Related Parties: Net revenues from related parties accounted for approximately 11% and 16% of the consolidated net revenues for the years ended June 30, 2014 and 2013, respectively. Net management fee receivables from the related medical practices accounted for approximately 12% and 9% of the consolidated accounts receivable for the years ended June 30, 2014 and 2013, respectively.

See Note 3 regarding the Company’s concentrations in the healthcare industry.

Fair Value of Financial Instruments

The financial statements include various estimated fair value information at June 30, 2014 and 2013, as required by ASC topic 820, "Disclosures about Fair Value of Financial Instruments". Such information, which pertains to the Company's financial instruments, is based on the requirements set forth in that Statement and does not purport to represent the aggregate net fair value to the Company.

The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value:

Cash and cash equivalents: The carrying amount approximates fair value because of the short-term maturity of those instruments.

Receivable and accounts payable: The carrying amounts approximate fair value because of the short maturity of those instruments.

Notes receivable: The carrying amount approximates fair value because the discounted present value of the cash flow generated by the parties approximates the carrying value of the amounts due to the Company.

Long-term debt, notes payable and accounts payable: The carrying amounts of debt and notes payable approximate fair value due to the length of the maturities, the interest rates being tied to market indices and/or due to the interest rates not being significantly different from the current market rates available to the Company.

All of the Company's financial instruments are held for purposes other than trading.

Recent Accounting Pronouncements

The FASB has issued ASU No. 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (a consensus of the FASB Emerging Issues Task Force). The amendments in this ASU state that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, except as follows. To the extent a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date under the tax law of the applicable jurisdiction to settle any additional income taxes that would result from the disallowance of a tax position or the tax law of the applicable jurisdiction does not require the entity to use, and the entity does not intend to use, the deferred tax asset for such purpose, the unrecognized tax benefit should be presented in the financial statements as a liability and should not be combined with deferred tax assets. The amendments in this ASU are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. Early adoption is permitted. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Retrospective application is permitted. The adoption of this standard did not have a material impact on the Company’s consolidated financial position and results of operations.

The FASB has issued ASU No. 2014-09, Revenue from Contracts with Customers. This ASU supercedes the revenue recognition requirements in Accounting Standards Codification 605 - Revenue Recognition and most industry-specific guidance throughout the Codification. The standard requires that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This ASU is effective on January 1, 2017 and should be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the ASU recognized at the date of initial application. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial position and results of operations.

FASB, the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of June 30, 2014 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly affected our financial accounting measures or disclosures had they been in effect during 2014 or 2013, and it does not believe that any of those pronouncements will have a significant impact on our consolidated financial statements at the time they become effective.

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year presentation. The reclassifications did not have any effect on reported net income for any periods presented.

NOTE_3_ACCOUNTS_RECEIVABLE_MED

NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE	12 Months Ended
	Jun. 30, 2014
Receivables [Abstract]	'
NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE	'
	NOTE 3 – ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE

	The Company’s customers are concentrated in the healthcare industry.

	Accounts Receivable

	Credit risk with respect to the Company’s accounts receivable related to product sales and service and repair fees is limited due to the customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.

	Medical Receivable

	Medical receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs, patient’s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The carrying amount of the medical receivable is reduced by an allowance that reflects management’s best estimate of the amounts that will not be collected. The Company continuously monitors collections from its clients and maintains an allowance for bad debts based upon the Company’s historical collection experience. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings, specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.

	Management and Other Fees Receivable

	The Company’s receivables from the related and non-related professional corporations (“PCs”) substantially consist of fees outstanding under management agreements. Payment of the outstanding fees is dependent on collection by the PCs of fees from third party medical reimbursement organizations, principally insurance companies and health management organizations.

	Payment of the management fee receivables from the PC’s may be impaired by the inability of the PC’s to collect in a timely manner their medical fees from the third party payors, particularly insurance carriers covering automobile no-fault and workers compensation claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately 50% and 41%, respectively, of the PCs’ 2014 and 2013 net revenues were derived from no-fault and personal injury protection claims. The Company considers the aging of its accounts receivable in determining the amount of allowance for doubtful accounts. The Company generally takes all legally available steps to collect its receivables. Credit losses associated with the receivables are provided for in the consolidated financial statements and have historically been within management's expectations.

	Net revenues from management and other fees charged to the related medical practices accounted for approximately 11% and 16%, of the consolidated net revenues for the years ended June 30, 2014 and 2013, respectively.

	Tallahassee Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI & Diagnostic Center, PA (all related medical practices) entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which have arisen under each individual management agreement.

	The following table sets forth the number of our facilities for the year end June 30, 2014 and 2013.

		For The Year Ended June 30,
		2014			2013
	Total Facilities Owned or Managed (at Beginning of Year)		24			11
	Facilities Added by:
	Acquisition		—			14
	Internal development		1			—
	Managed Facilities Closed		(1	)		(1	)
	Total Facilities Owned or Managed (at End of Year)		24			24

NOTE_4_COSTS_AND_ESTIMATED_EAR

NOTE 4 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS AND CUSTOMER ADVANCES	12 Months Ended
	Jun. 30, 2014
Notes to Financial Statements	'
NOTE 4 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS AND CUSTOMER ADVANCES	'
	NOTE 4 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS AND CUSTOMER ADVANCES

	Information relating to uncompleted contracts as of June 30, 2014 and 2013 is as follows:

		As of June 30,
		2014		2013
	Costs incurred on uncompleted contracts	$	1,884,984	$	1,482,384
	Estimated earnings		1,745,608		1,191,141
			3,630,592		2,673,525
	Less: Billings to date		3,013,000		2,370,000
		$	617,592	$	303,525

	Included in the accompanying consolidated balance sheets under the following captions:

		As of June 30,
		2014		2013
	Costs and estimated earnings in excess of billings on uncompleted contracts	$	759,809	$	445,742
	Less: Billings in excess of costs and estimated earnings on uncompleted contracts		142,217		142,217
		$	617,592	$	303,525

NOTE_5_INVENTORIES

NOTE 5 - INVENTORIES	12 Months Ended
NOTE 5 - INVENTORIES	Jun. 30, 2014
Inventory Disclosure [Abstract]	'
NOTE 5 - INVENTORIES	'
	NOTE 5 – INVENTORIES

	Inventories included in the accompanying consolidated balance sheets consist of:

		As of June 30,
		2014		2013
	Purchased parts, components and supplies	$	2,093,671	$	1,783,847
	Work-in-process		349,865		293,241
		$	2,443,536	$	2,077,088

NOTE_6_PROPERTY_AND_EQUIPMENT

NOTE 6 - PROPERTY AND EQUIPMENT	12 Months Ended
NOTE 6 - PROPERTY AND EQUIPMENT	Jun. 30, 2014
Property, Plant and Equipment [Abstract]	'
NOTE 6 - PROPERTY AND EQUIPMENT	'
	NOTE 6 - PROPERTY AND EQUIPMENT

	Property and equipment, at cost, less accumulated depreciation and amortization, at June 30, 2014 and 2013, is comprised of:

		As of June 30,
		2014		2013
	Diagnostic equipment under capital leases	$	620,307	$	620,307
	Diagnostic equipment		17,396,797		18,567,787
	Research, development and		3,510,224		3,500,902
	demonstration equipment		3,510,224		3,500,902
	Machinery and equipment		2,069,055		4,987,159
	Furniture and fixtures		2,550,627		2,952,449
	Leasehold improvements		5,593,148		5,669,338
	Building		939,614		939,614
			32,679,772		37,237,556
	Less: Accumulated depreciation and amortization		17,650,043		19,713,062
		$	15,029,729	$	17,524,494


	Depreciation and amortization of property and equipment for the years ended June 30, 2014 and 2013 was $2,458,113 and $1,554,458, respectively.

	Depreciation and amortization of diagnostic equipment under capital leases for the years ended June 30, 2014 and 2013 was $95,026 and $248,123, respectively. Accumulated depreciation and amortization of diagnostic equipment under capital leases for the years ended June 30, 2014 and 2013 was $620,307 and $525,281, respectively.

	During the year ended June 30, 2014, the Company has retired assets that were fully depreciated with a cost and accumulated depreciation basis of $4,418,903.

NOTE_7_OTHER_INTANGIBLE_ASSETS

NOTE 7 - OTHER INTANGIBLE ASSETS	12 Months Ended
NOTE 7 - OTHER INTANGIBLE ASSETS	Jun. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
NOTE 7 - OTHER INTANGIBLE ASSETS	'
	NOTE 7 - OTHER INTANGIBLE ASSETS

	Other intangible assets, net of accumulated amortization, at June 30, 2014 and 2013 are comprised of:

			As of June 30,
			2014				2013
	Capitalized software developmentcosts		$	7,418,436			$	7,668,959
	Patents and copyrights			4,408,011				4,193,800
	Non-competition agreements			4,100,000				4,100,000
	Customer relationships			3,800,000				3,800,000
				19,726,447				19,762,759
	Less: Accumulated amortization			9,217,604				7,858,511
			$	10,508,843			$	11,904,248

	Information related to the above intangible assets for the years ended June 30, 2014 and 2013 is as follows:

			As of June 30,
			2014				2013
	Balance – Beginning of Year		$	11,904,248			$	3,835,179
	Amounts capitalized			214,211				9,359,907
	Abandon software or patents written off			(250,523	)			(66,619	)
	Impairment of management agreement			—				(357,500	)
	Amortization			(1,359,093	)			(866,719	)
	Balance – End of Year		$	10,508,843			$	11,904,248

	Amortization of patents and copyrights for the years ended June 30, 2014 and 2013 amounted to $178,836 and $168,631, respectively.

	Amortization of capitalized software development costs for the years ended June 30, 2014 and 2013 was $407,876 and $335,350, respectively.

	Amortization of management agreement for the years ended June 30, 2014 and 2013 amounted to $0 and $100,833, respectively.

	Amortization of non-competition agreements for the years ended June 30, 2014 and 2013 amounted to $585,714 and $195,238, respectively.

	Amortization of customer relationships for the years ended June 30, 2014 and 2013 amounted to $186,667 and $66,667, respectively.

	The estimated amortization of other intangible assets for the five years ending June 30, 2019 and thereafter is as follows:

	For the Years Ending June 30,				Total				Patents and Copyrights		Capitalized Software Development Costs		Non-		Customer Relationships
	For the Years Ending June 30,				Total				Patents and Copyrights		Capitalized Software Development Costs		competition		Customer Relationships
		2015			$	1,328,315			$	189,559	$	363,042	$	585,714	$	190,000
		2016				1,347,439				205,114		366,611		585,714		190,000
		2017				1,368,582				220,668		372,200		585,714		190,000
		2018				1,329,294				230,647		322,933		585,714		190,000
		2019				1,043,968				228,665		39,589		585,714		190,000
		Thereafter				4,091,245				1,104,100		—		390,478		2,596,667
					$	10,508,843			$	2,178,753	$	1,464,375	$	3,319,048	$	3,546,667

	The weighted average amortization period for other intangible assets is 11.0 years and they have no expected residual value.

NOTE_8_CAPITAL_STOCK

NOTE 8 - CAPITAL STOCK	12 Months Ended
NOTE 8 - CAPITAL STOCK	Jun. 30, 2014
Notes to Financial Statements	'
NOTE 8 - CAPITAL STOCK	'
	NOTE 8 - CAPITAL STOCK

	Common Stock

	Cash dividends payable on the common stock shall, in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock.

	Class B Common Stock

	Class B common stock is convertible into shares of common stock on a one-for-one basis. Class B common stock has 10 votes per share. There were 146 and 146 of such shares outstanding at June 30, 2014 and 2013, respectively.

	Class C Common Stock

	On April 3, 1995, the stockholders ratified a proposal creating a new Class C common stock and authorized the exchange offering of three shares of Class C common stock for each share of the Company's outstanding Class B common stock. The Class C common stock has 25 votes per share, as compared to 10 votes per share for the Class B common stock and one vote per share for the common stock. The Class C common stock was offered on a three-for-one basis to the holders of the Class B common stock. Although having greater voting power, each share of Class C common stock has only one-third of the rights of a share of Class B common stock to dividends and distributions. Class C common stock is convertible into shares of common stock on a three-for-one basis.

	Class A Non-Voting Preferred Stock

	On April 3, 1995, the stockholders ratified a proposal consisting of the creation of a new class of Class A non-voting preferred stock with special dividend rights and the declaration of a stock dividend on the Company's common stock consisting of one share of Class A non-voting preferred stock for every five shares of common stock. The stock dividend was payable to holders of common stock on October 20, 1995. Class A non-voting preferred stock issued pursuant to such stock dividend approximates 313,000 shares.

	The Class A non-voting preferred stock is entitled to a special dividend equal to 3-1/4% of first $10 million, 4-1/2% of next $20 million and 5-1/2% on amounts in excess of $30 million of the amount of any cash awards or settlements received by the Company in connection with the enforcement of five of the Company's patents in its patent lawsuits, less the revised special dividend payable on the common stock with respect to one of the Company's patents.

	The Class A non-voting preferred stock participates on an equal per share basis with the common stock in any dividends declared and ranks equally with the common stock on distribution rights, liquidation rights and other rights and preferences (other than the voting rights).

	Stock Bonus Plans

	On April 23, 2010, the Board approved the 2010 Stock Bonus Plan. The plan entitles the Company to reserve 2,000,000 shares of common stock. On August 10, 2010, the Company filed Form S-8 to register the 2,000,000 shares. As of June 30, 2014, 958,367 shares of common stock of FONAR were available for future grant under this plan. For the years ended June 30, 2014 and 2013, 46,708 and 67,870 shares were issued, respectively.

	Options

	The Company has stock option plans, which provide for the awarding of incentive and non-qualified stock options to employees, directors and consultants who may contribute to the success of the Company. The options granted vest either immediately or ratably over a period of time from the date of grant, typically three or four years, at a price determined by the Board of Directors or a committee of the Board of Directors, generally the fair value of the Company's common stock at the date of grant. The options must be exercised within ten years from the date of grant.

	FONAR’s 2002 Incentive Stock Option Plan (the “FONAR 2002 Plan”), adopted on July 1, 2002, is intended to qualify as an incentive stock option plan under Section 422A of the Internal Revenue Code of 1954, as amended. The FONAR 2002 Plan permits the issuance of stock options covering an aggregate of 100,000 shares of common stock of FONAR. The options have an exercise price equal to the fair market value of the underlying stock on the date the option is granted, are nontransferable, are exercisable for a period not exceeding ten years and expire upon the voluntary termination of employment. The FONAR 2002 Plan terminated on June 30, 2012. During the year ended June 30, 2014, 6,610 options expired, therefore no options remain outstanding.

	FONAR’s 2005 Incentive Stock Option Plan (the “FONAR 2005 Plan”), adopted on February 16, 2005,is intended to qualify as an incentive stock option plan under Section 422A of the Internal Revenue Code of 1954, as amended. The FONAR 2005 Plan permits the issuance of stock options covering an aggregate of 80,000 shares of common stock of FONAR. The options have an exercise price equal to the fair value of the underlying stock on the date the option is granted, are non-transferable, are exercisable for a period not exceeding ten years, and expire upon the voluntary termination of employment. The FONAR 2005 Plan will terminate on February 14, 2015. As of June 30, 2014, 70,000 shares of common stock of FONAR were available for future grant under this Plan.

	Stock option activity and weighted average exercise prices under these plans and grants for the years ended June 30, 2014 and 2013 were as follows:

		Number of Options			Weighted Average Exercise Price		Aggregate Intrinsic Value
	Outstanding, June 30, 2012		14,022			27.76		—
	Granted		—			—		—
	Exercised		—			—		—
	Forfeited / Expired		(7,412	)		26.65		—
	Outstanding, June 30, 2013		6,610			29		—
	Granted					—		—
	Exercised		—			—		—
	Forfeited / Expired		(6,610	)		29		—
	Outstanding, June 30, 2014		—			—		—
	Exercisable at:
	30-Jun-13		6,610		$	29
	30-Jun-14		—		$	—

NOTE_9_CONTROLLING_AND_NONCONT

NOTE 9 - CONTROLLING AND NONCONTROLLING INTERESTS	12 Months Ended
NOTE 9 - CONTROLLING AND NONCONTROLLING INTERESTS	Jun. 30, 2014
Noncontrolling Interest [Abstract]	'
NOTE 9 - CONTROLLING AND NON CONTROLLING INTERESTS	'
	NOTE 9 – CONTROLLING AND NONCONTROLLING INTERESTS

	On February 13, 2013 the Company entered into an agreement with outside investors to acquire a 50.5% controlling interest in a newly formed limited liability company, Health Diagnostics Management LLC (HDM). According to the February 13, 2013 LLC operating agreement of HDM there are two classes of members; Class A members and one Class B member. The Class A members have an ownership interest of 49.5% of HDM. The Class B member (HMCA) has an ownership of 50.5% of HDM. On all matters on which members may vote every member is entitled to cast the percentage of votes equal to their percentage of ownership interest. Profits and losses an all items of income, gain or loss, deductions or other allocations of the Company will be allocated among the members in the same proportions as their membership interests in the Company bear to all the Class A and Class B membership interests of the Company in the aggregate outstanding. All of the depreciation and amortization of the assets of the Company will be allocated solely to the Class A members, unless and until their interests have been redeemed by the Company in full pursuant to the provisions of the operating agreement. During March 2013 the Company contributed $20,200,000 to HDM and the group of outside investors contributed $19,800,000 for its non-controlling membership interest.

	To fund its capital contribution the Company borrowed a total of $14,000,000 from a bank in the form of a term loan aggregating $11,000,000 and a revolving credit loan aggregating $3,000,000. The term loan is payable in 60 consecutive monthly installments, commencing September 1, 2013. The term loan bears interest at 4.75% per annum and is payable monthly. The revolving credit loan is due March 5, 2016. The Company can prepay the loan in whole or in part in multiples of $100,000 at any time without penalty. The revolving credit note bears interest at a rate of 4% per annum and is payable monthly. All borrowings under the loan agreements are collateralized by substantially all of the Company’s assets. The loan agreements also contain certain financial covenants that must be met on a periodic basis.

	On March 5, 2013 HDM purchased from Health Diagnostics, LLC (“HD”) and certain of its subsidiaries, a business managing twelve (12) Stand-Up® MRI Centers and two (2) other scanning centers located in the States of New York and Florida for a total purchase price (including consideration of $1.5 million to outside investors) aggregating $35.9 million. Concurrently with the acquisition, HDM entered into several consulting and non-competition agreements for a consideration of $4.1 million. The acquisition was accounted for using the purchase method in accordance with ASC 805, “Business Combinations”. The accompanying consolidated financial statements include the operations of HDM from the date of acquisition. The Company recognizes and measures goodwill as of the acquisition date, as the excess of the fair value of the consideration paid over the fair value of the identified net assets acquired.

	The following table summarizes the estimated fair values of the assets and liabilities assumed at the acquisition date:

	Management fee receivable		$	6,667,259
	Medical receivables			7,389,953
	Prepaid expenses and other current assets			10,262
	Property and equipment			14,912,650
	Intangible assets			9,200,000
	Goodwill			1,767,098
	Other assets			332,949
	Other current liabilities			(6,323	)
	Long term debt			(273,848	)
	Net assets acquired		$	40,000,000


	The purchase price was allocated to the tangible and intangible assets and liabilities assumed based on estimates of their respective fair values at the date of acquisition with the remaining unallocated purchase price recorded as goodwill. Management is responsible for the valuation of net assets acquired and considered a number of factors, including valuations and appraisals, when estimating the fair values and estimated useful lives of acquired assets and liabilities. The intangible assets, excluding goodwill, are being amortized on a straight-line basis over their weighted average lives as follows:

				Fair Value
	Non compete		$	4,100,000				7 years
	Customer relationships			3,800,000				20 years
	Developed software			1,300,000				5 years
	Total intangible assets		$	9,200,000

	The following unaudited pro forma results of operations for the twelve months ended June 30, 2013 assumes that the above acquisitions were made at the beginning of the year of acquisition. The unaudited pro forma information does not purport to be indicative of the results that would have been obtained if the acquisitions had actually occurred at the beginning of the year prior to acquisition, nor of the results that may be reported in the future.


			Year ended
			30-Jun-13
	Total Revenues - Net			69,723,542
	Net Income - Controlling Interests			17,442,337
	Net Income Available to Common Stockholders			16,294,377
	Net Income Available to Class A Non-Voting Preferred Stockholders			855,597
	Net Income Available to Class C Common Stockholders			292,363
	Basic Net Income Per Common Share Available to Common Stockholders			2.75
	Diluted Net Income Per Common Share Available to Common Stockholders			2.69
	Basic and Diluted Income Per Share - Common C			0.76
	Weighted Average Basic Shares Outstanding			5,933,318
	Weighted Average Diluted Shares Outstanding			6,060,822
	Weighted Average Basic and Diluted Shares Outstanding - Class C Common			382,513



	HDM’s total net revenues and income from operations for the period from the acquisition date (March 5, 2013) to June 30, 2013 was $14,834,143 and $1,958,714, respectively.

	Amount of each class of members’ equity as of June 30, 2014 and 2013

			30-Jun-14								30-Jun-13
			Class A Members				Class B Member				Class A Members				Class B Member
	Opening Members’ Equity		$	19,526,475			$	20,763,830			$	—			$	—
	Share of Net Income			2,266,473				4,566,186				543,225				1,397,080
	Contributions			—				—				19,800,000				20,200,000
	Distributions			(4,133,250	)			(4,216,750	)			(816,750	)			(833,250	)
	Ending Members’ Equity		$	17,659,698			$	21,113,266			$	19,526,475			$	20,763,830


	On May 2, 2011, the Company completed a private placement of equity and succeeded in raising $6,000,000. The offering consisted of Preferred Class A membership interests in a newly formed limited liability company, Imperial Management Services, LLC (“Imperial”). The Class B membership interests in Imperial, all of which were retained by the Company’s subsidiary, HMCA, hold a 75% equity interest in Imperial. The Class A membership interests are entitled to receive a dividend of 18% per annum of their cash capital contribution of $6,000,000. HMCA contributed all of its assets, together with its liabilities, to Imperial as HMCA’s capital contribution. The Imperial operating agreement provides for the Class A members to receive priority distributions until their original capital contributions are returned. Dividends are payable quarterly beginning August 1, 2011. On May 1, 2014 and on May 1, 2013, the Company returned a portion of the Class A Members capital contribution in the amount of $1,125,100 and $1,424,900, respectively. As of June 30, 2014, the Company’s subsidiary, HMCA, now owns approximately 91% interest in Imperial Management Services.

Amount of each class of members’ equity as of June 30, 2014 and 2013

		30-Jun-14								30-Jun-13
			Class A Members				Class B Member				Class A Members				Class B Member
Opening Members’ Equity		$	3,599,519			$	7,772,781			$	4,918,365			$	3,824,945
Share of Net Income			536,913				3,306,536				959,254				3,947,836
Contributions			—				—				—				—
Distributions			(607,520	)			—				(853,200	)			—
Redemption			(1,125,100	)			—				(1,424,900	)			—
Ending Members’ Equity		$	2,403,812			$	11,079,317			$	3,599,519			$	7,772,781


On May 1, 2010, the Company purchased a 15.2% interest from an unrelated party of an entity that provides management services to a diagnostic center in the New York Metropolitan area. On January 1, 2011, the Company purchased an additional 34.8% interest by the issuance of a promissory note of $400,000. Commencing January 1, 2011, the Company consolidates the activity of this entity. On June 1, 2013, the Company purchased from the noncontrolling members their remaining 50% interest for $700,000.

The Company also has a 50% controlling interest in an entity which the Company consolidates, that provides management services to a diagnostic center in the New York Metropolitan area. The center began operations during January 2012. The noncontrolling interest as of June 30, 2014 and 2013 aggregated $531,474 and $559,221, respectively.

NOTE_10_LONGTERM_DEBT_NOTES_PA

NOTE 10 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES	12 Months Ended
	Jun. 30, 2014
Debt Disclosure [Abstract]	'
NOTE 10 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES	'
	NOTE 10 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES

	Long-term debt, notes payable and capital leases consist of the following:

			June 30,
			2014				2013
			$	439,983			$	461,648
	Note payable requiring monthly payments of interest at a rate of 7% until May 2009 followed by 240 monthly payments of $4,472 through October 2026. The loan is collateralized by a building with a net book value of $652,505 as of June 30, 2014.
				300,000				2,400,000
	The revolving credit note is due by March 5, 2016. The Company can prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of 4% per annum and is payable monthly. The loan is collateralized by substantially all of the Company’s assets. The loan also contains certain financial covenants that must be met on a periodic basis.
				9,349,994				11,000,000
	The term loan is payable with interest only for 6 consecutive months commencing at the inception of the loan followed by 60 consecutive monthly installments, commencing October 1, 2013. The term loan bears interest at 4.75% per annum and is payable monthly. The loan is collateralized by substantially all of the Company’s assets. The loan also contains certain financial covenants that must be met on a periodic basis.
				660,911				689,646
	Note payable requiring 12 consecutive interest only payments commencing at the inception of the loan followed by 48 consecutive monthly payments, commencing May 1, 2014. The note bears interest at a rate of 4.75% per annum and is payable monthly. The loan is collateralized by substantially all of the Company’s assets. The loan also contains certain financial covenants that must be met on a periodic basis.
				621,758				1,221,480
	Other (including capital leases for property and equipment).
				11,372,646				15,772,774
	Less: Current portion			2,890,816				2,885,769
			$	8,481,830			$	12,887,005


	The maturities of long-term debt over the next five years and thereafter are as follows:

	Years Ending June 30,
		2015			$	2,890,816
		2016				2,782,561
		2017				2,440,108
		2018				2,372,330
		2019				580,891
		Thereafter				305,940
					$	11,372,646

NOTE_11_INCOME_TAXES

NOTE 11 - INCOME TAXES	12 Months Ended
NOTE 11 - INCOME TAXES	Jun. 30, 2014
Income Tax Disclosure [Abstract]	'
NOTE 11 - INCOME TAXES	'
	NOTE 11 - INCOME TAXES

	ASC topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return and the benefit recognized and measured pursuant to the interpretation are referred to as “unrecognized benefits”. A liability is recognized (or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents an enterprise’s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying the provisions of ASC topic 740.

	In accordance with ASC topic 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and would be classified as “Interest expense, net”. Penalties if incurred would be recognized as a component of “Selling, general and administrative” expenses.

	The Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances, the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2009.

	The Company netted a deferred tax asset of $5,740,287 and a deferred tax liability of $583,990 as of June 30, 2014, primarily relating to net operating loss carryforwards of approximately $137,252,000 available to offset future taxable income through 2034. The net operating losses begin to expire in 2019 for federal tax purposes and in 2014 for state income tax purposes.

	The ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those temporary differences become deductible. The Company considers projected future taxable income and tax planning strategies in making this assessment. At present, the Company does have a sufficient history of income and anticipates profitability in the coming years and has concluded that it is more-likely-than-not that the Company will be able to realize a portion of its tax benefits in the near future and therefore a valuation allowance was established for the partial value of the deferred tax asset.

	A valuation allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the valuation. Should the Company continue to remain profitable in future periods with supportable trends, the valuation allowance will be reversed accordingly.

	Components of the current (benefit) provision for income taxes are as follows:

		Years Ended June 30,
		2014			2013
	Current:
	Federal	$	310,000		$	125,000
	State		24,093			71,001
	Deferred taxes		(2,682,405	)		(2,473,892	)
		$	(2,348,312	)	$	(2,277,891	)

	A reconciliation of the federal statutory income tax rate to the Company's effective tax rate as reported is as follows:

		Years Ended June 30,
		2014			2013
	Taxes at federal statutory rate		34	%		34	%
	State and local income taxes (benefit), net of federal benefit		6	%		6	%
	Permanent differences		(0.9	)%		0.6	%
	(Decrease) increase in the valuation allowance and true ups		(68.3	)%		(76.2	)%
	Effective income tax rate		(29.2	)%		(35.6	)%


	As of June 30, 2014, the Company has net operating loss (“NOL”) carryforwards of approximately $137,252,000 that will be available to offset future taxable income. The utilization of certain of the NOLs is limited by separate return limitation year rules pursuant to Section 1502 of the Internal Revenue Code.

	The Company has, for federal income tax purposes, research and development tax credit carryforwards aggregating $3,742,000, which are accounted for under the flow-through method. The Company also has $578,000 in alternative minimum tax credits.

	In addition, for New York State income tax purposes, the Company has tax credit carryforwards, aggregating approximately $1,133,000, which are accounted for under the flow-through method. The tax credit carryforwards expire during the years ending June 30, 2014 to June 30, 2029.

	Significant components of the Company's deferred tax assets and liabilities at June 30, 2014 and 2013 are as follows:

		June 30,
		2014			2013
	Deferred tax assets:
	Allowance for doubtful accounts	$	6,961,016		$	6,139,291
	Non-deductible accruals		65,108			264,062
	Net operating carryforwards		54,900,136			58,052,831
	Tax credits		5,644,097			5,873,204
	Property and equipment and depreciation		195,408			1,070,291
	Inventory		130,822			84,136
			67,896,587			71,483,815
	Valuation allowance		(62,156,300	)		(68,548,065	)
	Total deferred tax assets		5,740,287			2,935,750
	Deferred tax liabilities: Inventory		—			—
	Capitalized software development costs		(583,990	)		(461,858	)
	Total deferred tax liabilities		(583,990	)		(461,858	)
	Net deferred tax asset	$	5,156,297		$	2,473,892

	The valuation allowance for deferred tax assets decreased by approximately $6,392,000 during the year ended June 30, 2014 and decreased by approximately $5,206,000 during the year ended June 30, 2013.

NOTE_12_OTHER_CURRENT_LIABILIT

NOTE 12 - OTHER CURRENT LIABILITIES	12 Months Ended
NOTE 12 - OTHER CURRENT LIABILITIES	Jun. 30, 2014
Payables and Accruals [Abstract]	'
NOTE 12 - OTHER CURRENT LIABILITIES	'
	NOTE 12 - OTHER CURRENT LIABILITIES

	Included in other current liabilities are the following:

		June 30,
		2014		2013
	Accrued salaries, commissions and payroll taxes	$	834,324	$	710,897
	Accrued interest		117,480		117,480
	Litigation accruals		664,349		809,349
	Sales tax payable		2,665,181		2,858,652
	Legal and other professional fees		438,730		569,049
	Accounting fees		325,139		305,000
	Purchase scanners		450,000		—
	Insurance premiums		306,092		13,443
	Interest and penalty – sales tax		2,374,339		2,321,858
	Penalty – 401k plan		—		250,000
	Rent		—		147,665
	Other		848,399		390,968
		$	9,024,033	$	8,494,361

NOTE_13_COMMITMENTS_AND_CONTIN

NOTE 13 - COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Jun. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
NOTE 13 - COMMITMENTS AND CONTINGENCIES	'
	NOTE 13 - COMMITMENTS AND CONTINGENCIES

	Leases

	The Company rents its operating facilities and certain equipment, pursuant to operating lease agreements expiring at various dates through December 2022. The leases for certain facilities contain escalation clauses relating to increases in real property taxes as well as certain maintenance costs.

	Future minimum operating lease commitments consisted of the following at June 30, 2014:

	Year Ending		Facilities And Equipment (Operating Lease)
	June 30,
		2015	$	3,753,050
		2016		3,042,814
		2017		1,295,636
		2018		835,680
		2019		351,732
		Thereafter		894,072
		Total minimum obligations	$	10,172,984

	Rent expense for operating leases approximated $4,571,000 and $4,035,000, for the years ended June 30, 2014 and 2013, respectively. The expense for the year ended June 30, 2013 included an expense for early termination of a lease of approximately $690,000.

	Employee Benefit Plans

	The Company has a non-contributory 401(k) Plan (the “401(k) Plan”). The 401(k) Plan covers all non-union employees who are at least 21 years of age with no minimum service requirements. There were no employer contributions to the Plan for the years ended June 30, 2014 and 2013. (See Other Matters below)

	The stockholders of the Company approved the 2000 Employee Stock Purchase Plan (“ESPP”) at the Company’s annual stockholders’ meeting in April 2000. The ESPP provides for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%. This plan has not been put into effect as of June 30, 2014.

	Stipulation Agreements

	The Company has entered into stipulation agreements with a number of its creditors that in the aggregate total $305,916, which is included in other current liabilities and other liabilities on the Company’s balance sheet as of June 30, 2014. The monthly payments total $19,552.

	The amounts to be paid over the next three years are as follows:

	Year Ending June 30,
		2015	$	152,166
		2016		96,000
		2017		57,750
			$	305,916

	Litigation

	The Company is subject to legal proceedings and claims arising from the ordinary course of its business, including personal injury, customer contract and employment claims. In the opinion of management, the aggregate liability, if any, with respect to such actions, will not have a material adverse effect on the consolidated financial position or results of operations of the Company.

	On or about June 30, 2010, one of Fonar’s customers, Golden Triangle Company, commenced an action against Fonar and certain individual defendants employed or formerly employed by Fonar, in the United States District Court for the Eastern District of New York based on the alleged wrongful failure of Fonar to deliver a scanner in Kuwait. The claim alleged various causes of action including breach of contract, fraud, conspiracy to defraud and conversion.

	Golden Triangle Company v. Fonar Corporation et al, CV10-2933. The Plaintiff contracted with Fonar to purchase a scanner, and paid $1,455,500 in advance. The scanner was never delivered, but Plaintiff never designed a site for delivery either. Alleging other damages, fraud and deceptive trade practices, Plaintiff sought up to $5,000,000. Fonar made a motion to dismiss the complaint, the outcome of which left Plaintiff with only a cause of action for breach of contract. The claims against the individual officers and employees of Fonar were dismissed. Fonar filed its answer, together with a counterclaim alleging that the Plaintiff, by attempting to overcharge the end-customer, had damaged Fonar’s reputation and ability to sell in Kuwait. The case was settled in June 2013 for $480,000 in cash and 30,000 shares of Fonar’s common stock payable in installments. The Company recorded a gain of $755,500 on the statements of income for the year ended June 30, 2013.

	Jack Shapiro v. Fonar Corporation, Supreme Court of the State of New York, Nassau County, was commenced by plaintiff in July, 2009 to recover $500,000 based on Fonar’s failure to refund a deposit on an MRI scanner and termination of plaintiff’s sales representative agreement. Plaintiff alleged that the deposit on the machine was in part consideration for the sales representative agreement. Fonar’s view was that the sales agreement and sales representative agreement were separate and (1) Fonar was entitled to keep the deposit on the sale when plaintiff failed to proceed with the transaction and (2) properly terminated the sales representative agreement in accordance with its terms. During the year ended June 30, 2013, the case has been settled for $323,000 payable in installments, subject to the plaintiff obtaining a sale for Fonar and the payment of installments of the purchase price by the customer.

	Matt Malek Madison v. Fonar Corporation, United States District Court, Northern District of California, was commenced by plaintiff on August 27, 2007 to recover a down payment for a scanner in the amount of $300,000, with interest. The plaintiff sought costs of suit and attorney’s fees as well. Fonar answered the complaint and sued the plaintiff for breach of contract in the amount of $450,000. Although down payments are usually expressly non-refundable in Fonar’s quotations and agreements, in this case, the quotation contemplated the sale of four scanners, and provided that the deposit would be refundable with interest, if the customer were unable to find suitable locations in the San Francisco Bay area. The issue was whether the customer made a good faith effort to find locations; Fonar’s position was that the customer did not. The case went to trial before a judge; the parties submitted post-trial briefs, and judgment was awarded to the plaintiff. Fonar appealed the trial court’s decision, but on January 31, 2012, the U.S. Court of Appeals for the 9^th Circuit affirmed the lower court’s decision awarding the plaintiff the $300,000 deposit with prejudgment interest from July 1, 2006. Fonar sought to have the Court of Appeals reconsider the decision en banc, (by all or a larger number of the judges on the Circuit Court of Appeals), but this was not granted. Although the case has been concluded, the plaintiff has not taken any steps to collect the judgment. As of June 30, 2014 and 2013, $300,000 was included in the Company’s accrued expenses.

	Bonutti Research v. Fonar Corporation, Health Management Corporation of America, Health Diagnostics, LLC et al, was commenced on December 2, 2011. Bonutti Research filed a patent infringement action in the U.S. District Court for the Eastern District Court of New York, alleging that Fonar’s Upright® MRI scanners infringe plaintiff’s patent which relates to the moving of a patient into the scanner. Fonar believes plaintiff’s claims are without merit and further, that the patent is invalid. The parties have settled the case for $150,000 payable by Fonar in twelve installments and certain licenses and covenants not to sue. The $150,000 has been recorded in the Company’s consolidated statements of income for the year ended June 30, 2014.

	Bolt MRI Technologies v. Fonar Corporation, Health Management Corporation of America & Health Diagnostics, LLC, was commenced on July 22, 2013, when Bolt MRI Technologies filed an action against Fonar Corporation, Health Management Corporation of America and Health Diagnostics, LLC alleging infringement of the same patent which is the subject of the Bonutti case. Bolt alleged that the patent was assigned to Bolt. The settlement of the Bonutti case covers this case as well.

	Other Matters

	The Company is also delinquent in filing sales tax returns for certain states, for which the Company has transacted business. The Company has recorded tax obligations of $2,665,000 plus interest and penalties of approximately $2,374,000. The Company is in the process of determining its regulatory requirements in order to become compliant.

	On August 31, 2011 the Company submitted an application to the Internal Revenue Service to voluntarily correct required reporting and disclosure requirements regarding its 401(k) Employee Benefit Plan. On December 9, 2011, the Internal Revenue Service issued a favorable determination letter on the tax-qualified status of the 401K plan document and a favorable compliance statement. During December 2013, the Company submitted an application to the U.S. Department of Labor to voluntarily correct the late filing of prior Form 5500s (annual returns). The voluntary correction application is still pending. The Company, however, does not anticipate any additional penalties will be assessed by the U.S. Department of Labor. The Company has recorded provisions for any potential penalties totaling $250,000, which was the Company’s best estimate of its possible exposure for penalties at that time. The Company has engaged outside counsel to assist with the correction process and to obtain compliance with all reporting and disclosure requirements. The Company’s actions to obtain compliance have concluded successfully and the $250,000 reserve has been reversed.

	The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense. As of June 30, 2014 and 2013, the Company had approximately $344,000 and $0, respectively, in reserve for its self-funded health insurance programs. The reserves are included in “Other current liabilities” in the consolidated balance sheets.

	The Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing these reserves such as assessing historical paid claims, average lags between the claims’ incurred date, reported dates and paid dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in the periods covered by this report.

NOTE_14_OTHER_EXPENSE_INCOME

NOTE 14 - OTHER (EXPENSE) INCOME	12 Months Ended
NOTE 14 - OTHER (EXPENSE) INCOME	Jun. 30, 2014
Other Income and Expenses [Abstract]	'
NOTE 14 - OTHER (EXPENSE) INCOME	'
	NOTE 14 - OTHER (EXPENSE) INCOME

	Other (expense) income consists of:

		For the Years Ended June 30,
		2014			2013
	Loss from investment	$	—		$	(48,777	)
	Litigation settlement		13,586			716,250
	Loss on disposition of equipment		(657,350	)
	Gain on sale of equipment		40,000			557,473
	Impairment of management agreement		—			(357,500	)
	Other expense		(4,835	)		(141,958	)
		$	(608,599	)	$	725,488

NOTE_15_SUPPLEMENTAL_CASH_FLOW

NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION	12 Months Ended
NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION	Jun. 30, 2014
Supplemental Cash Flow Elements [Abstract]	'
NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION	'
	NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION

	During the years ended June 30, 2014 and 2013, the Company paid $668,475 and $389,907 for interest, respectively.

	During the years ended June 30, 2014 and 2013, the Company paid $349,501 and $277,000 for income taxes, respectively.

	Purchase consideration:

	Assets acquired:
	Management fee receivable	$	6,667,259
	Medical receivable		7,389,953
	Prepaid expenses and other current assets		10,262
	Property and equipment		14,912,650
	Intangible assets		9,200,000
	Goodwill		1,767,098
	Other assets		332,949
	Total assets acquired	$	40,280,171
	Less liabilities assumed:
	Other current liabilities	$	6,323
	Long term debt		273,848
	Total liabilities assumed	$	280,171
		$	40,000,000

NOTE_16_DUE_TO_RELATED_MEDICAL

NOTE 16 - DUE TO RELATED MEDICAL PRACTICES	12 Months Ended
NOTE 16 - DUE TO RELATED MEDICAL PRACTICES	Jun. 30, 2014
Related Party Transactions [Abstract]	'
NOTE 16 - DUE TO RELATED MEDICAL PRACTICES	'
	NOTE 16 – DUE TO RELATED MEDICAL PRACTICES

	In June 2009, an entity owned by the Company’s Chairman of the Board, Tallahassee Scanning Services PA, sold its Upright MRI scanning system to the Company for $550,000 in exchange for 35 monthly payments of $18,769 to be made over a three year period, commencing October 18, 2009 including interest at a rate of 10.41% per annum. The Company used this scanning system to fulfill a sales order with an unrelated customer. The unpaid balance of as of June 30, 2014 and 2013 was $134,880.

NOTE_17_SEGMENT_AND_RELATED_IN

NOTE 17 - SEGMENT AND RELATED INFORMATION	12 Months Ended
NOTE 17 - SEGMENT AND RELATED INFORMATION	Jun. 30, 2014
Segment Reporting [Abstract]	'
NOTE 17 - SEGMENT AND RELATED INFORMATION	'
	NOTE 17 - SEGMENT AND RELATED INFORMATION

	The Company provides segment data in accordance with the provisions of ASC topic 280, “Disclosures about Segments of an Enterprise and Related Information”.

	The Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging centers.

	The accounting policies of the segments are the same as those described in the summary of significant accounting policies. All intersegment sales are market-based. The Company evaluates performance based on income or loss from operations.

	Summarized financial information concerning the Company’s reportable segments is shown in the following table:

		Manufacturing and Servicing of Medical Equipment			Management of Diagnostic Imaging Centers			Totals
	Fiscal 2014:
	Net revenues from external customers	$	12,070,563		$	56,434,914		$	68,505,477
	Intersegment net revenues *	$	1,963,750		$	—		$	1,963,750
	Income from operations	$	468,793		$	11,833,876		$	12,302,669
	Depreciation and amortization	$	410,728		$	3,406,477		$	3,817,205
	Compensatory element of stock issuances	$	223,000		$	—		$	223,000
	Total identifiable assets	$	18,093,789		$	58,696,054		$	76,789,843
	Capital expenditures	$	234,275		$	600,633		$	834,908

	Fiscal 2013:
	Net revenues from external customers	$	14,891,075		$	34,250,739		$	49,141,814
	Intersegment net revenues *	$	1,200,000		$	—		$	1,200,000
	Income from operations	$	139,390		$	7,396,357		$	7,535,747
	Depreciation and amortization	$	541,551		$	1,879,626		$	2,421,177
	Compensatory element of stock issuances	$	415,021		$	—		$	415,021
	Total identifiable assets	$	15,071,225		$	58,079,425		$	73,150,650
	Capital expenditures	$	237,636		$	25,170,303		$	25,407,939

	.* Amounts eliminated in consolidation

	Export Product Sales

	The Company’s areas of operations are principally in the United States. The Company had export sales of medical equipment amounting to 42.4% and 3.8% of product sales revenues to third parties for the years ended June 30, 2014 and 2013, respectively.

	The foreign product sales, as a percentage of product sales to unrelated parties, were made to customers in the following countries:

		For the Years Ended June 30,
		2014			2013
	Abu Dhabi		29.8	%		-%
	Switzerland		12.4			—
	England		—			3.6
	Germany		—			0.1
	Libya		0.2			0.1
			42.4	%		3.8	%


	Foreign Service and Repair Fees

	The Company’s areas of service and repair are principally in the United States. The Company had foreign revenues of service and repair of medical equipment amounting to 8.8% and 8.2% of consolidated net service and repair fees for the years ended June 30, 2014 and 2013, respectively. The foreign service and repair fees, as a percentage of total service and repair fees, were provided principally to the following countries:

		For the Years Ended June 30,
		2014			2013
	Spain		1	%		0.9	%
	Puerto Rico		1.1			1
	Switzerland		1.1			1.1
	Germany		0.4			—
	England		2.6			2
	Holland		1.3			2.2
	Canada		0.2			—
	Australia		1.1			1
			8.8	%		8.2	%

The Company does not have any material assets outside of the United States.

NOTE_18_ALLOWANCE_FOR_DOUBTFUL

NOTE 18 - ALLOWANCE FOR DOUBTFUL ACCOUNTS	12 Months Ended
NOTE 18 - ALLOWANCE FOR DOUBTFUL ACCOUNTS	Jun. 30, 2014
Valuation and Qualifying Accounts [Abstract]	'
NOTE 18 - ALLOWANCE FOR DOUBTFUL ACCOUNTS	'
	NOTE 18 – ALLOWANCE FOR DOUBTFUL ACCOUNTS

	The following represents a summary of allowance for doubtful accounts for the years ended June 30, 2014 and 2013, respectively:

	Description	Balance June 30, 2013		Additions			Deductions		Balance June 30, 2014
	Accounts receivable	$	257,362	(1)$	—		$	—	$	257,362
	Management and other fees receivable		9,095,320	-1	1,806,299			—		10,901,619
	Management and other fees receivable - related medical practices		403,047		—			—		403,047
	Medical receivables		2,584,669	-1	10,333,082			—		12,917,751
	Advance and notes to related parties		202,379		—			—		202,379


	Description	Balance June 30, 2012		Additions			Deductions		Balance June 30, 2013
	Accounts receivables	$	1,852,987	(1)$	(92,454	)	$	1,503,171	$	257,362
	Management and other fees receivable		7,458,345	-1	950,000			—		9,095,320
	Management and other fees receivable - related medical practices		403,047		—			—		403,047
	Medical receivables		—	-1	2,584,669					2,584,669
	Advance and notes to related parties		239,791		—			37,412		202,379
	Notes receivable		65,000		—			65,000		—

	(1) Included in provision for bad debts.

NOTE_19_SUBSEQUENT_EVENTS

NOTE 19 - SUBSEQUENT EVENTS	12 Months Ended
NOTE 19 - SUBSEQUENT EVENTS	Jun. 30, 2014
Subsequent Events [Abstract]	'
NOTE 19 - SUBSEQUENT EVENTS	'
	NOTE 19 – SUBSEQUENT EVENTS

	The Company evaluates events that have occurred after the balance sheet date, but before the consolidated financial statements are issued.

	During the period from July 1, 2014 through September 29, 2014, the Company has issued 5,000 shares of common stock to employees and consultants as compensation valued at $53,200 under a stock bonus plan.

NOTE_2_SUMMARY_OF_SIGNIFICANT_1

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

12 Months Ended

Jun. 30, 2014

Accounting Policies [Abstract]

Principles of Consolidation

Use of Estimates

Inventories

Inventories consist of purchased parts, components and supplies, as well as work-in-process, and are stated at the lower of cost, determined on the first-in, first-out method, or market.

Property and Equipment

Diagnostic equipment under capital lease

2.5

Diagnostic equipment

5–13

Research, development and demonstration equipment

7-Mar

Machinery and equipment

7-Feb

Furniture and fixtures

9-Mar

Leasehold improvements

2–10

Building

Long-Lived Assets

Deferred Rent

Other Intangible Assets

1) Capitalized Software Development Costs

2) Patents and Copyrights

Amortization is calculated on the straight-line basis over a period ranging from 15 to 17 years.

3) Management Agreement

4) Non-Competition Agreements

The non-competition agreements are being amortized on the straight line basis over the length of the agreement (7 years).

5) Customer Relationships

Amortization is calculated on the straight line basis over 20 years.

Goodwill

Acquired Assets and Assumed Liabilities

Acquired assets and assumed liabilities

Revenue Recognition

Revenue on scanner service contracts is recognized on the straight-line method over the related contract period, usually one year.

Revenue from sales of other items is recognized upon shipment.

The Company’s patient fee revenue, net of contractual allowances and discounts less the provision for bad debts for the years ended June 30, 2014 and 2013 are summarized in the following table.

For the Year Ended June 30,

2014

2013

Commercial Insurance/ Managed Care

4,217,088

1,360,536

Medicare/Medicaid

1,443,020

541,602

Workers' Compensation/Personal Injury

13,369,956

3,597,416

Other

5,277,128

1,982,311

Patient Fee Revenue, net of contractual allowances and discounts

24,307,192

7,481,865

Provision for Bad Debts

(10,333,082

)

(2,584,669

)

Net Patient Fee Revenue

13,974,110

4,897,196

Allowance for Doubtful Accounts - Patient Fee

Allowance for Doubtful Accounts – Patient Fee

Research and Development Costs

Advertising Costs

Advertising costs are expensed as incurred. Advertising expense approximated $889,000 and $835,000 for the years ended June 30, 2014 and 2013, respectively.

Shipping Costs

Income Taxes

Customer Advances

Cash advances and progress payments received on sales orders are reflected as customer advances until such time as revenue recognition begins.

Earnings Per Share

30-Jun-14

Basic

Total

Common Stock

Class C Common Stock

Numerator:

Net income Available to common stockholders

10,396,130

9,720,030

172,189

Denominator:

Weighted average shares outstanding

6,009,822

382,513

Basic income per common share

1.73

1.62

0.45

Diluted

Denominator:

Weighted average shares outstanding

6,009,822

382,513

Class C Common Stock

127,504

—

Total Denominator for diluted earnings per share

6,137,326

382,513

Diluted income per common share

1.58

0.45

30-Jun-13

Basic

Total

Common Stock

Class C Common Stock

Numerator:

Net income Available to common stockholders

8,678,542

8,107,367

145,467

Denominator:

Weighted average shares outstanding

5,933,318

382,513

Basic income per common share

1.46

1.37

0.38

Diluted

Denominator:

Weighted average shares outstanding

5,933,318

382,513

Class C Common Stock

127,504

—

Total Denominator for diluted earnings per share

6,060,822

382,513

Diluted income per common share

1.34

0.38

Cash and Cash Equivalents

The Company considers all short-term highly liquid investments with a maturity of three months or less when purchased to be cash equivalents.

Concentration of Credit Risk

See Note 3 regarding the Company’s concentrations in the healthcare industry.

Fair Value of Financial Instruments

The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value:

Cash and cash equivalents: The carrying amount approximates fair value because of the short-term maturity of those instruments.

Receivable and accounts payable: The carrying amounts approximate fair value because of the short maturity of those instruments.

All of the Company's financial instruments are held for purposes other than trading.

Recent Accounting Pronouncements

Reclassifications

Certain prior year amounts have been reclassified to conform to the current year presentation. The reclassifications did not have any effect on reported net income for any periods presented.

NOTE_2_SUMMARY_OF_SIGNIFICANT_2

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Jun. 30, 2014
Accounting Policies [Abstract]	'
Estimated Useful Life in Years for Property and Equipment	'
	Estimated Useful Lives in Years For Property and Equipment

	Diagnostic equipment under capital lease		2.5
	Diagnostic equipment		5–13
	Research, development and demonstration equipment		7-Mar
	Machinery and equipment		7-Feb
	Furniture and fixtures		9-Mar
	Leasehold improvements		2–10
	Building		28
Patient Fee Revenue - Net	'
	Patient Fee Revenue - Net

		For the Year Ended June 30,
		2014			2013
	Commercial Insurance/ Managed Care	$	4,217,088		$	1,360,536
	Medicare/Medicaid		1,443,020			541,602
	Workers' Compensation/Personal Injury		13,369,956			3,597,416
	Other		5,277,128			1,982,311
	Patient Fee Revenue, net of contractual allowances and discounts		24,307,192			7,481,865
	Provision for Bad Debts		(10,333,082	)		(2,584,669	)
	Net Patient Fee Revenue	$	13,974,110		$	4,897,196
Earnings Per Share	'
	Earnings Per Share

		30-Jun-14
	Basic		Total			Common Stock			Class C Common Stock
	Numerator:
	Net income Available to common stockholders	$	10,396,130		$	9,720,030		$	172,189
	Denominator:
	Weighted average shares outstanding		6,009,822			6,009,822			382,513
	Basic income per common share	$	1.73		$	1.62		$	0.45
	Diluted
	Denominator:
	Weighted average shares outstanding					6,009,822			382,513
	Class C Common Stock					127,504			—
	Total Denominator for diluted earnings per share					6,137,326			382,513
	Diluted income per common share				$	1.58		$	0.45


		30-Jun-13
	Basic		Total			Common Stock			Class C Common Stock
	Numerator:
	Net income Available to common stockholders	$	8,678,542		$	8,107,367		$	145,467
	Denominator:
	Weighted average shares outstanding		5,933,318			5,933,318			382,513
	Basic income per common share	$	1.46		$	1.37		$	0.38
	Diluted
	Denominator:
	Weighted average shares outstanding					5,933,318			382,513
	Class C Common Stock					127,504			—
	Total Denominator for diluted earnings per share					6,060,822			382,513
	Diluted income per common share		.		$	1.34		$	0.38

NOTE_3_ACCOUNTS_RECEIVABLE_MED1

NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)	12 Months Ended
	Jun. 30, 2014
Notes to Financial Statements	'
Total Facilities Owned or Managed	'
	Total Facilities Owned or Managed

		For The Year Ended June 30,
		2014			2013
	Total Facilities Owned or Managed (at Beginning of Year)		24			11
	Facilities Added by:
	Acquisition		—			14
	Internal development		1			—
	Managed Facilities Closed		(1	)		(1	)
	Total Facilities Owned or Managed (at End of Year)		24			24

NOTE_4_COSTS_AND_ESTIMATED_EAR1

NOTE 4 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS AND CUSTOMER ADVANCES (Tables)	12 Months Ended
	Jun. 30, 2014
Notes to Financial Statements	'
Costs and Estimated Earnings on Uncompleted Contracts	'
	Costs and Estimated Earnings on Uncompleted Contracts

		As of June 30,
		2014		2013
	Costs incurred on uncompleted contracts	$	1,884,984	$	1,482,384
	Estimated earnings		1,745,608		1,191,141
			3,630,592		2,673,525
	Less: Billings to date		3,013,000		2,370,000
		$	617,592	$	303,525


		As of June 30,
		2014		2013
	Costs and estimated earnings in excess of billings on uncompleted contracts	$	759,809	$	445,742
	Less: Billings in excess of costs and estimated earnings on uncompleted contracts		142,217		142,217
		$	617,592	$	303,525

NOTE_5_INVENTORIES_Tables

NOTE 5 - INVENTORIES (Tables)	12 Months Ended
NOTE 5 - INVENTORIES (Tables)	Jun. 30, 2014
Inventory Disclosure [Abstract]	'
Inventories	'
	Inventories

		As of June 30,
		2014		2013
	Purchased parts, components and supplies	$	2,093,671	$	1,783,847
	Work-in-process		349,865		293,241
	Inventories	$	2,443,536	$	2,077,088

NOTE_6_PROPERTY_AND_EQUIPMENT_

NOTE 6 - PROPERTY AND EQUIPMENT (Tables)	12 Months Ended
NOTE 6 - PROPERTY AND EQUIPMENT (Tables)	Jun. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property and Equipment	'
	Property and Equipment - Net

		As of June 30,
		2014		2013
	Diagnostic equipment under capital leases	$	620,307	$	620,307
	Diagnostic equipment		17,396,797		18,567,787
	Research, development and		3,510,224		3,500,902
	demonstration equipment		3,510,224		3,500,902
	Machinery and equipment		2,069,055		4,987,159
	Furniture and fixtures		2,550,627		2,952,449
	Leasehold improvements		5,593,148		5,669,338
	Building		939,614		939,614
			32,679,772		37,237,556
	Less: Accumulated depreciation and amortization		17,650,043		19,713,062
	Property and Equipment - Net	$	15,029,729	$	17,524,494

NOTE_7_OTHER_INTANGIBLE_ASSETS1

NOTE 7 - OTHER INTANGIBLE ASSETS (Tables)	12 Months Ended
NOTE 7 - OTHER INTANGIBLE ASSETS (Tables)	Jun. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Other Intagible Assets - Net	'
	Other Intangible Assets - Net

			As of June 30,
			2014				2013
	Capitalized software developmentcosts		$	7,418,436			$	7,668,959
	Patents and copyrights			4,408,011				4,193,800
	Non-competition agreements			4,100,000				4,100,000
	Customer relationships			3,800,000				3,800,000
				19,726,447				19,762,759
	Less: Accumulated amortization			9,217,604				7,858,511
	Other Intangible Assets - Net		$	10,508,843			$	11,904,248

Schedule Of Other Intangle Assets	'
	Schedule of Other Intangible Assets

			As of June 30,
			2014				2013
	Balance – Beginning of Year		$	11,904,248			$	3,835,179
	Amounts capitalized			214,211				9,359,907
	Abandon software or patents written off			(250,523	)			(66,619	)
	Impairment of management agreement			—				(357,500	)
	Amortization			(1,359,093	)			(866,719	)
	Balance – End of Year		$	10,508,843			$	11,904,248

Amortization of Other Intangible Assets	'
	Amortization of Intangible Assets - Net

	For the Years Ending June 30,				Total				Patents and Copyrights		Capitalized Software Development Costs		Non-		Customer Relationships
	For the Years Ending June 30,				Total				Patents and Copyrights		Capitalized Software Development Costs		competition		Customer Relationships
		2015			$	1,328,315			$	189,559	$	363,042	$	585,714	$	190,000
		2016				1,347,439				205,114		366,611		585,714		190,000
		2017				1,368,582				220,668		372,200		585,714		190,000
		2018				1,329,294				230,647		322,933		585,714		190,000
		2019				1,043,968				228,665		39,589		585,714		190,000
		Thereafter				4,091,245				1,104,100		—		390,478		2,596,667
					$	10,508,843			$	2,178,753	$	1,464,375	$	3,319,048	$	3,546,667

NOTE_8_CAPITAL_STOCK_Tables

NOTE 8 - CAPITAL STOCK (Tables)	12 Months Ended
NOTE 8 - CAPITAL STOCK (Tables)	Jun. 30, 2014
Notes to Financial Statements	'
Stock Option Activity and Weighted Average Exercise Prices under Fonar Incentive Stock Option Plans	'
	Stock Option Activity and Weighted Average Exercise Prices under Fonar Incentive Stock Option Plans

		Number of Options			Weighted Average Exercise Price		Aggregate Intrinsic Value
	Outstanding, June 30, 2012		14,022			27.76		—
	Granted		—			—		—
	Exercised		—			—		—
	Forfeited / Expired		(7,412	)		26.65		—
	Outstanding, June 30, 2013		6,610			29		—
	Granted					—		—
	Exercised		—			—		—
	Forfeited / Expired		(6,610	)		29		—
	Outstanding, June 30, 2014		—			—		—
	Exercisable at:
	30-Jun-13		6,610		$	29
	30-Jun-14		—		$	—

NOTE_9_CONTROLLING_AND_NONCONT1

NOTE 9 - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)	12 Months Ended
NOTE 9 - CONTROLLING AND NONCONTROLLING INTERESTS (Tables)	Jun. 30, 2014
Noncontrolling Interest [Abstract]	'
Estimated Fair Value of Assets and Liabilities Assumed at Acquisition Date of Health Diagnostics Management (HDM)	'
	Estimated Fair Values of the Assets and Liabilities Assumed at the Acquisition Date of Health Diagnostics Management LLC (HDM)

	Management fee receivable	$	6,667,259
	Medical receivables		7,389,953
	Prepaid expenses and other current assets		10,262
	Property and equipment		14,912,650
	Intangible assets		9,200,000
	Goodwill		1,767,098
	Other assets		332,949
	Other current liabilities		(6,323	)
	Long term debt		(273,848	)
	Net assets acquired	$	40,000,000

Fair Value of Intangible Assets, Acquired in Acquisition, Excluding Goodwill	'
	Fair Value of Intangible Assets, Acquired in Acquisition, Excluding Goodwill

			Fair Value
	Non compete	$	4,100,000			7 years
	Customer relationships		3,800,000			20 years
	Developed software		1,300,000			5 years
	Total intangible assets	$	9,200,000

Unaudited Pro Forma Results of Operations	'
	Unaudited Pro Forma results of Operations

		Year ended
		30-Jun-13
	Total Revenues - Net		69,723,542
	Net Income - Controlling Interests		17,442,337
	Net Income Available to Common Stockholders		16,294,377
	Net Income Available to Class A Non-Voting Preferred Stockholders		855,597
	Net Income Available to Class C Common Stockholders		292,363
	Basic Net Income Per Common Share Available to Common Stockholders		2.75
	Diluted Net Income Per Common Share Available to Common Stockholders		2.69
	Basic and Diluted Income Per Share - Common C		0.76
	Weighted Average Basic Shares Outstanding		5,933,318
	Weighted Average Diluted Shares Outstanding		6,060,822
	Weighted Average Basic and Diluted Shares Outstanding - Class C Common		382,513

Class Aand B Members' Equity (HDM Acquisition)	'
	Class A and B Members’ Equity (HDM Acquisition)

		30-Jun-14						30-Jun-13
		Class A Members			Class B Member			Class A Members			Class B Member
	Opening Members’ Equity	$	19,526,475		$	20,763,830		$	—		$	—
	Share of Net Income		2,266,473			4,566,186			543,225			1,397,080
	Contributions		—			—			19,800,000			20,200,000
	Distributions		(4,133,250	)		(4,216,750	)		(816,750	)		(833,250	)
	Ending Members’ Equity	$	17,659,698		$	21,113,266		$	19,526,475		$	20,763,830

Class Aand B Members' Equity (Imperial Management Services)	'
	Class A and B Members’ Equity (Imperial Management Services, LLC)

		30-Jun-14						30-Jun-13
			Class A Members			Class B Member			Class A Members			Class B Member
	Opening Members’ Equity	$	3,599,519		$	7,772,781		$	4,918,365		$	3,824,945
	Share of Net Income		536,913			3,306,536			959,254			3,947,836
	Contributions		—			—			—			—
	Distributions		(607,520	)		—			(853,200	)		—
	Redemption		(1,125,100	)		—			(1,424,900	)		—
	Ending Members’ Equity	$	2,403,812		$	11,079,317		$	3,599,519		$	7,772,781

NOTE_10_LONGTERM_DEBT_NOTES_PA1

NOTE 10 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES (Tables)	12 Months Ended
	Jun. 30, 2014
Debt Disclosure [Abstract]	'
Long-Term Debt, Notes Payable And Capital Leases	'
	Long-term Debt, Notes Payable and Capital Leases

			June 30,
			2014				2013
			$	439,983			$	461,648
	Note payable requiring monthly payments of interest at a rate of 7% until May 2009 followed by 240 monthly payments of $4,472 through October 2026. The loan is collateralized by a building with a net book value of $652,505 as of June 30, 2014.
				300,000				2,400,000
	The revolving credit note is due by March 5, 2016. The Company can prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of 4% per annum and is payable monthly. The loan is collateralized by substantially all of the Company’s assets. The loan also contains certain financial covenants that must be met on a periodic basis.
				9,349,994				11,000,000
	The term loan is payable with interest only for 6 consecutive months commencing at the inception of the loan followed by 60 consecutive monthly installments, commencing October 1, 2013. The term loan bears interest at 4.75% per annum and is payable monthly. The loan is collateralized by substantially all of the Company’s assets. The loan also contains certain financial covenants that must be met on a periodic basis.
				660,911				689,646
	Note payable requiring 12 consecutive interest only payments commencing at the inception of the loan followed by 48 consecutive monthly payments, commencing May 1, 2014. The note bears interest at a rate of 4.75% per annum and is payable monthly. The loan is collateralized by substantially all of the Company’s assets. The loan also contains certain financial covenants that must be met on a periodic basis.
				621,758				1,221,480
	Other (including capital leases for property and equipment).
				11,372,646				15,772,774
	Less: Current portion			2,890,816				2,885,769
	Long-term Debt, Notes Payable and Capital Leases		$	8,481,830			$	12,887,005

Maturities Of Long-Term Debt	'
	Maturities of Long-Term Debt

	Years Ending June 30,
		2015			$	2,890,816
		2016				2,782,561
		2017				2,440,108
		2018				2,372,330
		2019				580,891
		Thereafter				305,940
					$	11,372,646

NOTE_11_INCOME_TAXES_Tables

NOTE 11 - INCOME TAXES (Tables)	12 Months Ended
NOTE 11 - INCOME TAXES (Tables)	Jun. 30, 2014
Income Tax Disclosure [Abstract]	'
Components Of Current (Benefit) Provision For Income Taxes	'
	Components of the Current (Benefit) Provision for Income Taxes

		Years Ended June 30,
		2014			2013
	Current:
	Federal	$	310,000		$	125,000
	State		24,093			71,001
	Deferred taxes		(2,682,405	)		(2,473,892	)
		$	(2,348,312	)	$	(2,277,891	)

Reconciliation Of Federal Statutory Income Tax Rate To Company's Effective Tax Rate	'
	Reconciliation of the Federal Statutory Income Tax Rate to the Company's Effective Tax Rate

		Years Ended June 30,
		2014			2013
	Taxes at federal statutory rate		34	%		34	%
	State and local income taxes (benefit), net of federal benefit		6	%		6	%
	Permanent differences		(0.9	)%		0.6	%
	(Decrease) increase in the valuation allowance and true ups		(68.3	)%		(76.2	)%
	Effective income tax rate		(29.2	)%		(35.6	)%

Components Of Company's Deferred Tax Assets And Liabilities	'
	Components of the Company's Deferred Tax Assets and Liabilities

		June 30,
		2014			2013
	Deferred tax assets:
	Allowance for doubtful accounts	$	6,961,016		$	6,139,291
	Non-deductible accruals		65,108			264,062
	Net operating carryforwards		54,900,136			58,052,831
	Tax credits		5,644,097			5,873,204
	Property and equipment and depreciation		195,408			1,070,291
	Inventory		130,822			84,136
			67,896,587			71,483,815
	Valuation allowance		(62,156,300	)		(68,548,065	)
	Total deferred tax assets		5,740,287			2,935,750
	Deferred tax liabilities: Inventory		—			—
	Capitalized software development costs		(583,990	)		(461,858	)
	Total deferred tax liabilities		(583,990	)		(461,858	)
	Net deferred tax asset	$	5,156,297		$	2,473,892

NOTE_12_OTHER_CURRENT_LIABILIT1

NOTE 12 - OTHER CURRENT LIABILITIES (Tables)	12 Months Ended
NOTE 12 - OTHER CURRENT LIABILITIES (Tables)	Jun. 30, 2014
Payables and Accruals [Abstract]	'
Other Current Liabilities	'
	Other Current Liabilities

		June 30,
		2014		2013
	Accrued salaries, commissions and payroll taxes	$	834,324	$	710,897
	Accrued interest		117,480		117,480
	Litigation accruals		664,349		809,349
	Sales tax payable		2,665,181		2,858,652
	Legal and other professional fees		438,730		569,049
	Accounting fees		325,139		305,000
	Purchase scanners		450,000		—
	Insurance premiums		306,092		13,443
	Interest and penalty – sales tax		2,374,339		2,321,858
	Penalty – 401k plan		—		250,000
	Rent		—		147,665
	Other		848,399		390,968
	Other Current Liabilities	$	9,024,033	$	8,494,361

NOTE_13_COMMITMENTS_AND_CONTIN1

NOTE 13 - COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
NOTE 13 - COMMITMENTS AND CONTINGENCIES (Tables)	Jun. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Future Minimums Operating Lease Commitments	'
	Leases

	Future Minimum Operating Lease Commitments

	Year Ending		Facilities And Equipment (Operating Lease)
	June 30,		Facilities And Equipment (Operating Lease)
		2015	$	3,753,050
		2016		3,042,814
		2017		1,295,636
		2018		835,680
		2019		351,732
		Thereafter		894,072
		Total minimum obligations	$	10,172,984

Stipulation Agreements	'
	Stipulation Agreements

	Year Ending June 30,
		2015	$	152,166
		2016		96,000
		2017		57,750
		Stipulation Agreements	$	305,916

NOTE_14_OTHER_INCOME_Tables

NOTE 14 - OTHER INCOME (Tables)	12 Months Ended
NOTE 14 - OTHER INCOME (Tables)	Jun. 30, 2014
Other Income and Expenses [Abstract]	'
Other (Expense) Income - Net	'
	Other (Expense) Income - Net

		For the Years Ended June 30,
		2014			2013
	Loss from investment	$	—		$	(48,777	)
	Litigation settlement		13,586			716,250
	Loss on disposition of equipment		(657,350	)
	Gain on sale of equipment		40,000			557,473
	Impairment of management agreement		—			(357,500	)
	Other expense		(4,835	)		(141,958	)
	Other (Expense) Income - Net	$	(608,599	)	$	725,488

NOTE_15_SUPPLEMENTAL_CASH_FLOW1

NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION (Tables)	12 Months Ended
NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION (Tables)	Jun. 30, 2014
Supplemental Cash Flow Elements [Abstract]	'
Supplemental Cash Flow (Purchase Consideration) From Business Combination (HDM Acquisition)	'
	Supplemental Cash Flow (Purchase Consideration) From Business Combination (HDM Acquisition)

	Assets acquired:
	Management fee receivable	$	6,667,259
	Medical receivable		7,389,953
	Prepaid expenses and other current assets		10,262
	Property and equipment		14,912,650
	Intangible assets		9,200,000
	Goodwill		1,767,098
	Other assets		332,949
	Total assets acquired	$	40,280,171
	Less liabilities assumed:
	Other current liabilities	$	6,323
	Long term debt		273,848
	Total liabilities assumed	$	280,171
		$	40,000,000

NOTE_17_SEGMENT_AND_RELATED_IN1

NOTE 17 - SEGMENT AND RELATED INFORMATION (Tables)	12 Months Ended
NOTE 17 - SEGMENT AND RELATED INFORMATION (Tables)	Jun. 30, 2014
Segment Reporting [Abstract]	'
Summarized Segment Financial Information	'
	Summarized Segment Financial Information


		Manufacturing and Servicing of Medical Equipment			Management of Diagnostic Imaging Centers			Totals
	Fiscal 2014:
	Net revenues from external customers	$	12,070,563		$	56,434,914		$	68,505,477
	Intersegment net revenues *	$	1,963,750		$	—		$	1,963,750
	Income from operations	$	468,793		$	11,833,876		$	12,302,669
	Depreciation and amortization	$	410,728		$	3,406,477		$	3,817,205
	Compensatory element of stock issuances	$	223,000		$	—		$	223,000
	Total identifiable assets	$	18,093,789		$	58,696,054		$	76,789,843
	Capital expenditures	$	234,275		$	600,633		$	834,908

	Fiscal 2013:
	Net revenues from external customers	$	14,891,075		$	34,250,739		$	49,141,814
	Intersegment net revenues *	$	1,200,000		$	—		$	1,200,000
	Income from operations	$	139,390		$	7,396,357		$	7,535,747
	Depreciation and amortization	$	541,551		$	1,879,626		$	2,421,177
	Compensatory element of stock issuances	$	415,021		$	—		$	415,021
	Total identifiable assets	$	15,071,225		$	58,079,425		$	73,150,650
	Capital expenditures	$	237,636		$	25,170,303		$	25,407,939

	.* Amounts eliminated in consolidation

Export Product Sales	'
	Foreign Product Sales, as a Percentage of Product Sales to Unrelated Parties

		For the Years Ended June 30,
		2014			2013
	Abu Dhabi		29.8	%		-%
	Switzerland		12.4			—
	England		—			3.6
	Germany		—			0.1
	Libya		0.2			0.1
			42.4	%		3.8	%

Foreign Service and Repair Fees	'
	Foreign Service and Repair Fees, as a Percentage of Total Service and Repair Fees

		For the Years Ended June 30,
		2014			2013
	Spain		1	%		0.9	%
	Puerto Rico		1.1			1
	Switzerland		1.1			1.1
	Germany		0.4			—
	England		2.6			2
	Holland		1.3			2.2
	Canada		0.2			—
	Australia		1.1			1
			8.8	%		8.2	%

NOTE_18_ALLOWANCE_FOR_DOUBTFUL1

NOTE 18 - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)	12 Months Ended
NOTE 18 - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Tables)	Jun. 30, 2014
Valuation and Qualifying Accounts [Abstract]	'
Summary of Allowance For Doubtful Accounts	'
	Summary of Allowance for Doubtful Accounts

	Description	Balance June 30, 2013		Additions			Deductions		Balance June 30, 2014
	Accounts receivable	$	257,362	(1)$	—		$	—	$	257,362
	Management and other fees receivable		9,095,320	-1	1,806,299			—		10,901,619
	Management and other fees receivable - related medical practices		403,047		—			—		403,047
	Medical receivables		2,584,669	-1	10,333,082			—		12,917,751
	Advance and notes to related parties		202,379		—			—		202,379


	Description	Balance June 30, 2012		Additions			Deductions		Balance June 30, 2013
	Accounts receivables	$	1,852,987	(1)$	(92,454	)	$	1,503,171	$	257,362
	Management and other fees receivable		7,458,345	-1	950,000			—		9,095,320
	Management and other fees receivable - related medical practices		403,047		—			—		403,047
	Medical receivables		—	-1	2,584,669					2,584,669
	Advance and notes to related parties		239,791		—			37,412		202,379
	Notes receivable		65,000		—			65,000		—

	(1) Included in provision for bad debts.

NOTE_2_SUMMARY_OF_SIGNIFICANT_3

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES PROPERTY AND EQUIPMENT - Useful Life in Years - (Details)	12 Months Ended
	Jun. 30, 2014
Diagnostic Equipment Under Capital Lease \| Weighted Average	'
Property, Plant and Equipment	'2 years 6 months
Diagnostic Equipment \| Minimum	'
Property, Plant and Equipment	'5 years
Diagnostic Equipment \| Maximum	'
Property, Plant and Equipment	'13 years
Research, development, and demonstration equipment \| Minimum	'
Property, Plant and Equipment	'3 years
Research, development, and demonstration equipment \| Maximum	'
Property, Plant and Equipment	'7 years
Machinery and Equipment \| Minimum	'
Property, Plant and Equipment	'2 years
Machinery and Equipment \| Maximum	'
Property, Plant and Equipment	'7 years
Furniture and Fixtures \| Minimum	'
Property, Plant and Equipment	'3 years
Furniture and Fixtures \| Maximum	'
Property, Plant and Equipment	'9 years
Leasehold Improvements \| Minimum	'
Property, Plant and Equipment	'2 years
Leasehold Improvements \| Maximum	'
Property, Plant and Equipment	'10 years
Building \| Weighted Average	'
Property, Plant and Equipment	'28 years

NOTE_2_SUMMARY_OF_SIGNIFICANT_4

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Patient Fee Revenue Recognition - (Details) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Patient fee revenue, net of contractual allowances and discounts	$24,307,192	$7,481,865
Patient fee revenue provision for bad debts	-10,333,082	-2,584,669
Net patient fee revenue	13,974,110	4,897,196
Commercial Insurance / Managed Care	'	'
Patient fee revenue, net of contractual allowances and discounts	4,217,088	1,360,536
Medicare/Medicaid	'	'
Patient fee revenue, net of contractual allowances and discounts	1,443,020	541,602
Workers Compensation/Personal Injury	'	'
Patient fee revenue, net of contractual allowances and discounts	13,369,956	3,597,416
Other	'	'
Patient fee revenue, net of contractual allowances and discounts	$5,277,128	$1,982,311

NOTE_2_SUMMARY_OF_SIGNIFICANT_5

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Basic Numerator: Net income Available to common stockholders	$10,396,130	$8,678,542
Basic Denominator: Weighted Average Shares outstanding	6,009,822	5,933,318
Total Denominator for diluted earnings per share	6,137,326	6,060,822
Common Stock	'	'
Basic Numerator: Net income Available to common stockholders	9,720,030	8,107,367
Basic Denominator: Weighted Average Shares outstanding	6,009,822	5,933,318
Basic income per common share	$1.62	$1.37
Diluted Denominator: Weighted Average Shares outstanding	6,009,822	5,933,318
Class C Common Stock	127,504	127,504
Total Denominator for diluted earnings per share	6,137,326	6,060,822
Diluted income per common share	$1.58	$1.34
Class C Common	'	'
Basic Numerator: Net income Available to common stockholders	$172,189	$145,467
Basic Denominator: Weighted Average Shares outstanding	382,513	382,513
Basic income per common share	$0.45	$0.38
Diluted Denominator: Weighted Average Shares outstanding	382,513	382,513
Class C Common Stock	'	'
Total Denominator for diluted earnings per share	382,513	382,513
Diluted income per common share	$0.45	$0.38

NOTE_3_ACCOUNTS_RECEIVABLE_MED2

NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE-Total Facilities (Details)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
	MRICenter	MRICenter
Note 3 - Accounts Receivable Medical Receivable And Management And Other Fees Receivable-Total Facilities Details	'	'
Total Facilities Owned or Managed (at Beginning of Year)	24	11
Facilities Added by:	'	'
Acquisition	'	14
Internal development	1	'
Managed Facilities Closed	-1	-1
Total Facilities Owned or Managed (at End of Year)	24	24

NOTE_4_COSTS_ESTIMATED_EARNING

NOTE 4 - COSTS, ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS, CUSTOMER ADVANCES - Costs, Earnings, Billings - (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
Notes to Financial Statements	'	'
Costs incurred on uncompleted contracts	$1,884,984	$1,482,384
Estimated earnings	1,745,608	1,191,141
Less: billings to date	3,013,000	2,370,000
Unbilled contracts receivable	$617,592	$303,525

NOTE_4_COSTS_ESTIMATED_EARNING1

NOTE 4 - COSTS, ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS, CUSTOMER ADVANCES -Uncompleted Contracts (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
Notes to Financial Statements	'	'
Costs and estimated earnings in excess of billings on uncompleted contracts	$759,809	$445,742
Less: Billings in excess of costs and estimated earnings on uncompleted contracts	-142,217	-142,217
Unbilled contracts receivable	$617,592	$303,525

NOTE_5_INVENTORIES_Inventories

NOTE 5 - INVENTORIES - Inventories (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
Inventory Disclosure [Abstract]	'	'
Purchased parts, components and supplies	$2,093,671	$1,783,847
Work-in-process	349,865	293,241
Inventories	$2,443,536	$2,077,088

NOTE_6_PROPERTY_AND_EQUIPMENT_1

NOTE 6 - PROPERTY AND EQUIPMENT - Property and Equipment (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
Property, Plant and Equipment [Abstract]	'	'
Diagnostic equipment under capital leases	$620,307	$620,307
Diagnostic equipment	17,396,797	18,567,787
Research, development and demonstration equipment	3,510,224	3,500,902
Machinery and equipment	2,069,055	4,987,159
Furniture and fixtures	2,550,627	2,952,449
Leasehold improvements	5,593,148	5,669,338
Building	939,614	939,614
Property and Equipment Subtotal Before Accumulated depreciation and amortization	32,679,772	37,237,556
Less: Accumulated depreciation and amortization	-17,650,043	-19,713,062
Property and Equipment Total AfterAccumulated depreciation and amortization	$15,029,729	$17,524,494

NOTE_7_OTHER_INTANGIBLE_ASSETS2

NOTE 7 - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'	'
Capitalized software development costs	$7,418,436	$7,668,959
Patents and copyrights	4,408,011	4,193,800
Non-competition agreements	4,100,000	4,100,000
Customer Relationships	3,800,000	3,800,000
Less: Accumulated amortization	-9,217,604	-7,858,511
Other Intangible Assets - Net	$10,508,843	$11,904,248

NOTE_7_OTHER_INTANGIBLE_ASSETS3

NOTE 7 - OTHER INTANGIBLE ASSETS - Schedule Of Intangle Assets - (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'	'
Balance - Beginning of Year	$11,904,248	$3,835,179
Amounts capitalized	214,211	9,359,907
Abandon patents written off	-250,523	-66,619
Impairment of Management Agreement	'	-357,500
Amortization	-1,359,093	-866,719
Balance - End of Year	$10,508,843	$11,904,248

NOTE_7_OTHER_INTANGIBLE_ASSETS4

NOTE 7 - OTHER INTANGIBLE ASSETS - Forward Looking Schedule of Other Intangible Assets - (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
2015	$1,328,315	'
2016	1,347,439	'
2017	1,368,582	'
2018	1,329,294	'
2019	1,043,968	'
Thereafter	4,091,245	'
Other Intangible Assets - Net	10,508,843	11,904,248
Patents and Copyrights	'	'
2015	189,559	'
2016	205,114	'
2017	220,668	'
2018	230,647	'
2019	228,665	'
Thereafter	1,104,100	'
Other Intangible Assets - Net	2,178,753	'
Capitalized software development costs	'	'
2015	363,042	'
2016	366,611	'
2017	372,200	'
2018	322,933	'
2019	39,589	'
Thereafter	'	'
Other Intangible Assets - Net	1,464,375	'
Non-competition agreements	'	'
2015	585,714	'
2016	585,714	'
2017	585,714	'
2018	585,714	'
2019	585,714	'
Thereafter	390,478	'
Other Intangible Assets - Net	3,319,048	'
Customer Relationships	'	'
2015	190,000	'
2016	190,000	'
2017	190,000	'
2018	190,000	'
2019	190,000	'
Thereafter	2,596,667	'
Other Intangible Assets - Net	$3,546,667	'

NOTE_8_CAPITAL_STOCK_Stock_Opt

NOTE 8 - CAPITAL STOCK - Stock Option Activity - (Details) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Number of Options	'	'
Options Outstanding, beginning balance	6,610	14,022
Shares Granted	'	'
Shares Exercised	'	'
Shares Expired	-6,610	-7,412
Options Outstanding, ending balance	'	6,610
Weighted Average Exercise Price	'	'
Options Outstanding, beginning balance	$29	$27.76
Shares Granted	'	'
Forfeited / Expired	'	$26.65
Options Outstanding, ending balance	'	$29
Aggregate Intrinsic Value	'	'
Outstanding, beginning balance	'	'
Granted	'	'
Exercised	'	'

NOTE_9_CONTROLLING_AND_NONCONT2

NOTE 9 - CONTROLLING AND NONCONTROLLING INTERESTS - Net Assets Acquired (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013	Mar. 05, 2013	Mar. 05, 2013	Mar. 05, 2013
			Health Diagnostics Management LLC (HDM)	Health Diagnostics Management LLC (HDM)	Health Diagnostics Management LLC (HDM)
				Management fee receivable	Medical receivables
Fee receivable	'	'	'	$6,667,259	$7,389,953
Prepaid expenses and other current assets	1,011,358	1,054,551	10,262	'	'
Property and equipment - Net	15,029,729	17,524,494	14,912,650	'	'
Intangible assets	'	'	9,200,000	'	'
Goodwill	1,767,098	1,767,098	1,767,098	'	'
Other assets	922,096	1,153,304	332,949	'	'
Other current liabilities	9,024,033	8,494,361	-6,323	'	'
Long term debt	'	'	-273,848	'	'
Net assets acquired	'	'	$40,000,000	'	'

NOTE_9_CONTROLLING_AND_NONCONT3

NOTE 9 - CONTROLLING AND NONCONTROLLING INTERESTS - Total Intangible Assets (Details) (USD $)	12 Months Ended
	Jun. 30, 2014
Fair Value	$9,200,000
Non-competition agreements	'
Fair Value	4,100,000
Estimated Useful Life	'7 years
Customer Relationships	'
Fair Value	3,800,000
Estimated Useful Life	'20 years
Developed Software	'
Fair Value	$1,300,000
Estimated Useful Life	'5 years

NOTE_9_CONTROLLING_AND_NONCONT4

NOTE 9 - CONTROLLING AND NONCONTROLLING INTERESTS - Unaudited Proforma Results of Operations (Details) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Total Revenues - Net	$68,505,477	$49,141,814
Net Income - Controlling Interests	10,396,130	8,678,542
Weighted Average Basic Shares Outstanding	6,009,822	5,933,318
Weighted Average Diluted Shares Outstanding	6,137,326	6,060,822
Common Stock	'	'
Net Income - Controlling Interests	9,720,030	8,107,367
Basic Net Income Per Common Share Available to Common Stockholders	$1.62	$1.37
Diluted Net Income Per Common Share Available to Common Stockholders	$1.58	$1.34
Weighted Average Basic Shares Outstanding	6,009,822	5,933,318
Weighted Average Diluted Shares Outstanding	6,137,326	6,060,822
Class C Common	'	'
Net Income - Controlling Interests	172,189	145,467
Basic Net Income Per Common Share Available to Common Stockholders	$0.45	$0.38
Diluted Net Income Per Common Share Available to Common Stockholders	$0.45	$0.38
Weighted Average Basic Shares Outstanding	382,513	382,513
Weighted Average Diluted Shares Outstanding	382,513	382,513
Health Diagnostics Management LLC (HDM)	'	'
Total Revenues - Net	'	69,723,542
Net Income - Controlling Interests	'	17,442,337
Weighted Average Basic Shares Outstanding	'	5,933,318
Weighted Average Diluted Shares Outstanding	'	6,060,822
Health Diagnostics Management LLC (HDM) \| Common Stock	'	'
Net Income Available to Stockholders	'	16,294,377
Basic Net Income Per Common Share Available to Common Stockholders	'	$2.75
Diluted Net Income Per Common Share Available to Common Stockholders	'	$2.69
Health Diagnostics Management LLC (HDM) \| Class A Non-Voting Preferred	'	'
Net Income Available to Stockholders	'	855,597
Health Diagnostics Management LLC (HDM) \| Class C Common	'	'
Net Income Available to Stockholders	'	$292,363
Basic Net Income Per Common Share Available to Common Stockholders	'	$0.76
Diluted Net Income Per Common Share Available to Common Stockholders	'	$0.76
Weighted Average Basic Shares Outstanding	'	382,513
Weighted Average Diluted Shares Outstanding	'	382,513

NOTE_9_CONTROLLING_AND_NONCONT5

NOTE 9 - CONTROLLING AND NONCONTROLLING INTERESTS - HDM Members Equity (Details) (HDM Equity, USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Class A Members	'	'
Opening Members Equity	$19,526,475	'
Share of Net Income	2,266,473	543,225
Contributions	'	19,800,000
Distributions	-4,133,250	-816,750
Ending Members Equity	17,659,698	19,526,475
Class B Members	'	'
Opening Members Equity	20,763,830	'
Share of Net Income	4,566,186	1,397,080
Contributions	'	20,200,000
Distributions	-4,216,750	-833,250
Ending Members Equity	$21,113,266	$20,763,830

NOTE_9_CONTROLLING_AND_NONCONT6

NOTE 9 - CONTROLLING AND NONCONTROLLING INTERESTS - Members Equity (Details) (HDM and Imperial Equity, USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Class A Members	'	'
Opening Members' Equity	$3,599,519	$4,918,365
Share of Net Income	536,913	959,254
Contributions to Members'Equity	'	'
Distributions to Members' Equity	-607,520	-853,200
Redemption	-1,125,100	-1,424,900
Ending Members' Equity at June 30,	2,403,812	3,599,519
Class B Members	'	'
Opening Members' Equity	7,772,781	3,824,945
Share of Net Income	3,306,536	3,947,836
Contributions to Members'Equity	'	'
Distributions to Members' Equity	'	'
Redemption	'	'
Ending Members' Equity at June 30,	$11,079,317	$7,772,781

NOTE_10_LONGTERM_DEBT_NOTES_PA2

NOTE 10 - LONG-TERM DEBT, NOTES PAYABLE AND CAPITAL LEASES Long-Term Debt, Notes Payable And Capital Leases - (Details) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Less: Current portion	($2,890,816)	($2,885,769)
Long Term Debt and Capital Lease Obligations	8,481,830	12,887,005
Long Term Note 1	'	'
Long Term Note Payable	439,983	461,648
Long Term Note Payable Description	'Note payable requiring monthly payments of interest at a rate of 7% until May 2009 followed by 240 monthly payments of $4,472 through October 2026. The loan is collateralized by a building with a net book value of $652,505 as of June 30, 2014.	'
Long Term Note 2	'	'
Long Term Note Payable	300,000	2,400,000
Long Term Note Payable Description	'The revolving credit note is due by March 5, 2016. The Company can prepay the loan in whole or part in multiples of $100,000 at any time without penalty. The note bears interest at a rate of 4% per annum and is payable monthly. The loan is collateralized by substantially all of the CompanyBs assets. The loan also contains certain financial covenants that must be met on a periodic basis.	'
Long Term Note 3	'	'
Long Term Note Payable	9,349,994	11,000,000
Long Term Note Payable Description	'The term loan is payable with interest only for 6 consecutive months commencing at the inception of the loan followed by 60 consecutive monthly installments, commencing October 1, 2013. The term loan bears interest at 4.75% per annum and is payable monthly. The loan is collateralized by substantially all of the CompanyBs assets. The loan also contains certain financial covenants that must be met on a periodic basis.	'
Long Term Note 4	'	'
Long Term Note Payable	$660,911	$689,646
Long Term Note Payable Description	'Note payable requiring 12 consecutive interest only payments commencing at the inception of the loan followed by 48 consecutive monthly payments, commencing May 1, 2014. The note bears interest at a rate of 4.75% per annum and is payable monthly. The loan is collateralized by substantially all of the Company's assets. The loan also contains certain financial covenants that must be met on a periodic basis.	'

NOTE_10_LONGTERM_DEBT_NOTES_PA3

NOTE 10 - LONG-TERM DEBT, NOTES PAYABLE & CAPITAL LEASES - Maturities Of Long-Term Debt Over 5 Years - (Details) (USD $)	Jun. 30, 2014
Debt Disclosure [Abstract]	'
2015	$2,890,816
2016	2,782,561
2017	2,440,108
2018	2,372,330
2019	580,891
Thereafter	305,940
Long-Term Debt Over Five Years and Thereafter	$11,372,646

NOTE_11_INCOME_TAXES_Component

NOTE 11 - INCOME TAXES - Components Of Current (Benefit) Provision For Income Taxes - (Details) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Income Tax Disclosure [Abstract]	'	'
Current: Federal	$310,000	$125,000
Current: State	24,093	71,001
Total Deferred taxes	-2,682,405	-2,473,892
Benefit for Income Taxes	($2,348,312)	($2,277,891)

NOTE_11_INCOME_TAXES_Income_Ta

NOTE 11 - INCOME TAXES - Income Tax Rate Reconciliation (Details)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Note 11 - Income Taxes - Income Tax Rate Reconciliation Details	'	'
Taxes at federal statutory rate	34.00%	34.00%
State and local income taxes (benefit), net of federal benefit	6.00%	6.00%
Permanent differences taxes	-9.00%	0.60%
(Decrease) increase in the valuation allowance and true ups	-68.30%	-76.20%
Effective income tax rate	-29.20%	-35.60%

NOTE_11_INCOME_TAXES_Significa

NOTE 11 - INCOME TAXES - Significant Components Of Company's Deferred Tax Assets And Liabilities - (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
Income Tax Disclosure [Abstract]	'	'
Allowance for doubtful accounts	$6,961,016	$6,139,291
Non Deductible Accruals	65,108	264,062
Net operating carryforwards	54,900,136	58,052,831
Tax credits	5,644,097	5,873,204
Property and equipment and Depreciation	195,408	1,070,291
Inventory	130,822	84,136
Total Deferred Tax Assets	67,896,587	71,483,815
Valuation allowance	-62,156,300	-68,548,065
Total deferred tax assets	5,740,287	2,935,750
Inventory	'	'
Capitalized software development costs	-583,990	-461,858
Total deferred tax liabilities	-583,990	-461,858
Net deferred tax liabilities	$5,156,297	$2,473,892

NOTE_12_OTHER_CURRENT_LIABILIT2

NOTE 12 - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
Payables and Accruals [Abstract]	'	'
Accrued salaries, commissions and payroll taxes	$834,324	$710,897
Accrued interest	-117,480	-117,480
Litigation accruals	664,349	809,349
Sales tax payable	2,665,181	2,858,652
Legal and other professional fees	438,730	569,049
Accounting fees	325,139	305,000
Purchase Scanners	386,012	654,273
Insurance premiums	306,092	13,443
Other	848,399	390,968
Interest and penalty - sales tax	2,374,339	2,321,858
Penalty - 401k plan	'	250,000
Rent	'	147,665
Other current liabilities	$9,024,033	$8,494,361

NOTE_13_COMMITMENTS_AND_CONTIN2

NOTE 13 - COMMITMENTS AND CONTINGENCIES - Future Minimums Operating Lease Commitments - (Details) (USD $)	Jun. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Facilities And Equipment (Operating Lease) Due in 2015	$3,753,050
Facilities And Equipment (Operating Lease) Due in 2016	3,042,814
Facilities And Equipment (Operating Lease) Due in 2017	1,295,636
Facilities And Equipment (Operating Lease) Due in 2018	835,680
Facilities And Equipment (Operating Lease) Due in 2019	351,732
Facilities And Equipment (Operating Lease) Due Thereafter	894,072
Total minimum obligations	$10,172,984

NOTE_13_COMMITMENTS_AND_CONTIN3

NOTE 13 - COMMITMENTS AND CONTINGENCIES - Stipulation Agreements - (Details) (USD $)	Jun. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
2015	$152,166
2016	96,000
2017	57,750
Total Stipulation Agreements	$305,916

NOTE_14_OTHER_INCOME_Other_Inc

NOTE 14 - OTHER INCOME - Other Income - (Details) (USD $)	12 Months Ended
NOTE 14 - OTHER INCOME - Other Income - (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013
Other Income and Expenses [Abstract]	'	'
(Loss) income from investment	'	($48,777)
Litigation settlement	'	755,000
Loss on disposition of equipment	657,350	'
Gain on sale of equipment	'	557,473
Impairment on management agreement	'	357,500
Other expense	-4,835	-141,958
Total Other Income	($608,599)	$725,488

NOTE_15_SUPPLEMENTAL_CASH_FLOW2

NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION - Supplemental Cash Flow From Business Combination - (Details) (USD $)	Jun. 30, 2014	Jun. 30, 2013	Mar. 05, 2013	Mar. 05, 2013	Mar. 05, 2013
			Health Diagnostics Management LLC (HDM)	Health Diagnostics Management LLC (HDM)	Health Diagnostics Management LLC (HDM)
				Management fee receivable	Medical receivables
Assets acquired:	'	'	'	'	'
Account Receivable	'	'	'	$6,667,259	$7,389,953
Prepaid expenses and other current assets	1,011,358	1,054,551	10,262	'	'
Property and equipment	'	'	14,912,650	'	'
Intangible assets	'	'	9,200,000	'	'
Goodwill	1,767,098	1,767,098	1,767,098	'	'
Other assets	'	'	332,949	'	'
Total assets acquired	'	'	40,280,171	'	'
Less liabilities assumed:	'	'	'	'	'
Other current liabilities	-9,024,033	-8,494,361	6,323	'	'
Long term debt	'	'	273,848	'	'
Total liabilities assumed	'	'	280,171	'	'
Net assets acquired	'	'	$40,000,000	'	'

NOTE_17_SEGMENT_AND_RELATED_IN2

NOTE 17 - SEGMENT AND RELATED INFORMATION - Segment and Related Information - (Details) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Net revenues from external customers	$68,505,477	$49,141,814
Intersegment net revenues	1,963,750	1,200,000
Income from operations	12,302,669	7,535,747
Depreciation and amortization	3,817,205	2,421,177
Compensatory element of stock issuances	223,000	415,021
Total identifiable assets	76,789,843	73,150,650
Capital expenditures	834,908	25,407,939
Manufacturing And Servicing Of Medical Equipment	'	'
Net revenues from external customers	12,070,563	14,891,075
Intersegment net revenues	1,963,750	1,200,000
Income from operations	468,793	139,390
Depreciation and amortization	410,728	541,551
Compensatory element of stock issuances	223,000	415,021
Total identifiable assets	18,093,789	15,071,225
Capital expenditures	234,275	237,636
Management of Diagnostic Imaging Centers	'	'
Net revenues from external customers	56,434,914	34,250,739
Intersegment net revenues	'	'
Income from operations	11,833,876	7,396,357
Depreciation and amortization	3,406,477	1,879,626
Compensatory element of stock issuances	'	'
Total identifiable assets	58,696,054	58,079,425
Capital expenditures	$600,633	$25,170,303

NOTE_17_SEGMENT_AND_RELATED_IN3

NOTE 17 - SEGMENT AND RELATED INFORMATION - Export Product Sales - (Details)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Foreign Product Sales	42.40%	3.80%
United Arab Emerites	'	'
Foreign Product Sales	29.80%	'
Switzerland	'	'
Foreign Product Sales	12.40%	'
England	'	'
Foreign Product Sales	'	3.60%
Germany	'	'
Foreign Product Sales	'	0.10%
Libya	'	'
Foreign Product Sales	0.20%	0.10%

NOTE_17_SEGMENT_AND_RELATED_IN4

NOTE 17 - SEGMENT AND RELATED INFORMATION - Foreign Service and Repair Fees - (Details)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Foreign Service and Repair fees	8.80%	8.20%
Spain	'	'
Foreign Service and Repair fees	1.00%	0.90%
Puerto Rico	'	'
Foreign Service and Repair fees	1.10%	1.00%
Switzerland	'	'
Foreign Service and Repair fees	1.10%	1.10%
Germany	'	'
Foreign Service and Repair fees	0.40%	'
England	'	'
Foreign Service and Repair fees	2.60%	2.00%
Holland	'	'
Foreign Service and Repair fees	1.30%	2.20%
Canada	'	'
Foreign Service and Repair fees	0.20%	'
Australia	'	'
Foreign Service and Repair fees	1.10%	1.00%

NOTE_18_ALLOWANCE_FOR_DOUBTFUL2

NOTE 18 - ALLOWANCE FOR DOUBTFUL ACCOUNTS - Allowance For Doubtful Accounts (Details) (USD $) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Receivables from equipment sales and service contracts	'	'
Additions	'	($92,454)
Deductions	'	1,503,171
Balance Beginning	257,362	1,852,987
Balance Ending	257,362	257,362
Management fee receivable	'	'
Additions	1,806,299	950,000
Deductions	'	'
Balance Beginning	9,095,320	7,458,345
Balance Ending	10,901,619	9,095,320
Management fee receivable from related medical practices	'	'
Additions	'	'
Deductions	'	'
Balance Beginning	403,047	403,047
Balance Ending	403,047	403,047
Medical receivables	'	'
Additions	10,333,082	2,584,669
Deductions	'	'
Balance Beginning	2,584,669	'
Balance Ending	12,917,751	2,584,669
Advance and notes to related parties	'	'
Additions	'	'
Deductions	'	37,412
Balance Beginning	202,379	239,791
Balance Ending	202,379	202,379
Notes Receivable	'	'
Additions	'	'
Deductions	'	65,000
Balance Beginning	'	65,000
Balance Ending	'	'

NOTE_1_DESCRIPTION_OF_BUSINESS1

NOTE 1 - DESCRIPTION OF BUSINESS, LIQUIDITY AND CAPITAL RESOURCES (Details Narrative) (Health Diagnostics Management LLC (HDM), USD $)	Mar. 05, 2013
	MRICenter
Health Diagnostics Management LLC (HDM)	'
Cost of Majority Interest for Health Diagnostics Management LLC	$40,000,000
Stand-Up MRI scanners being managed b Health Diagnostics Management LLC	12
Recumbent MRI scanners being managed b Health Diagnostics Management LLC	2
Diagnostic Imaging Facilities Managed by Imperial Management LLC	11

NOTE_2_SUMMARY_OF_SIGNIFICANT_6

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
	MRICenter	Jun. 30, 2013
Maintenance and Repair Expenses	$1,037,000	$598,000
Impairment as a result of closing scanning center	'	357,500
Advertising Costs	889,000	835,000
Shipping and Handling Expense	1,885	5,838
Cash on Deposit in Bank	8,035,000	'
Cash FDIC insured Amount	250,000	'
Net revenues from related parties as a percentage of consolidated net revenues	11.00%	16.00%
Net management fee receivables from the related medical practices as a percentage of the consolidated accounts receivable	12.00%	9.00%
Management Agreements with Company - Non Related Medical Practices	17	'
Management Agreements with Company - Related Medical Practices	3	'
Management Agreements with Company - Total Medical Practices	20	'
Number of shares Upon Conversion of Class C Common Included in Diluted EPS for Common Shareholders	127,504	127,504
Diagnostic Imaging Facility	'	'
Contractual Fees for Services Rendered Minimum	35,000	'
Contractual Fees for Services Rendered Maximum	242,000	'
Medical Equipment	'	'
Contractual Fees for Services Rendered Minimum	2,000	'
Contractual Fees for Services Rendered Maximum	$19,000	'

NOTE_3_ACCOUNTS_RECEIVABLE_MED3

NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - (Details Narrative)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Note 3 - Accounts Receivable Medical Receivable And Management And Other Fees Receivable - Details Narrative	'	'
Percentage of PC's net revenue derived from no-fault and personal injury protection claims	50.00%	41.00%
Percentage of consolidated net revenue from management fees	11.00%	16.00%

NOTE_6_PROPERTY_AND_EQUIPMENT_2

NOTE 6 - PROPERTY AND EQUIPMENT- (Details Narrative) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Depreciation and amortization	$3,817,205	$2,421,177
Cost and accumulated depreciation basis of retired assets that were fully depreciated	4,418,903	'
Property and Equipment	'	'
Depreciation and amortization	2,458,113	1,554,458
Diagnostic Equipment Under Capital Lease	'	'
Depreciation and amortization	95,026	248,123
Accumulated depreciation and amortization	$620,307	$525,281

NOTE_7_OTHER_INTANGIBLE_ASSETS5

NOTE 7 - OTHER INTANGIBLE ASSETS - (Details Narrative) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Weighted average amortization period (years)	'11 years	'
Patents and Copyrights	'	'
Amortization other intangible assets	$178,836	$168,631
Capitalized software development costs	'	'
Amortization other intangible assets	407,876	335,350
Management Agreement	'	'
Amortization other intangible assets	'	100,833
Non-competition agreements	'	'
Amortization other intangible assets	585,714	195,238
Customer Relationships	'	'
Amortization other intangible assets	$186,667	$66,667

NOTE_8_CAPITAL_STOCK_Details_N

NOTE 8 - CAPITAL STOCK - (Details Narrative)	12 Months Ended
NOTE 8 - CAPITAL STOCK - (Details Narrative)	Jun. 30, 2014	Jun. 30, 2013	Aug. 10, 2010	Apr. 23, 2010	Feb. 16, 2005	Jul. 01, 2002
Shares reserved for 2010 Stock Bonus Plan	'	'	'	2,000,000	'	'
Shares Registered under Form S-8 for 2010 Stock Bonus Plan	'	'	2,000,000	'	'	'
Common Stock available under2010 Stock Bonus Plan	958,367	'	'	'	'	'
Shares issued under 2010 Stock Bonus Plan	46,708	67,870	'	'	'	'
Issuance of stock options for 2002 Stock Option Plan	'	'	'	'	'	100,000
Stock options expired under 2002 Stock Option Plan	6,610	'	'	'	'	'
Options outstanding under 2002 Stock Option Plan	0	'	'	'	'	'
Common stock available under 2005 Stock Option Plan	70,000	'	'	'	'	'
Common stock authorized under 2005 Stock Option Plan	'	'	'	'	80,000	'
Common Stock	'	'	'	'	'	'
Dividends Payable Nature	'Cash dividends payable on the common stock shall, in all cases, be on a per share basis, one hundred twenty percent (120%) of the cash dividend payable on shares of Class B common stock and three hundred sixty percent (360%) of the cash dividend payable on a share of Class C common stock.	'	'	'	'	'
Class B Members	'	'	'	'	'	'
Terms of Conversion	'Class B common stock is convertible into shares of common stock on a one-for-one basis.	'	'	'	'	'
Shares Outstanding	'There were 146 and 146 of such shares outstanding at June 30, 2014 and 2013, respectively.	'	'	'	'	'
Votes Per Share	'Class B common stock has 10 votes per share.	'	'	'	'	'
Class C Common	'	'	'	'	'	'
Terms of Conversion	'On April 3, 1995, the stockholders ratified a proposal creating a new Class C common stock and authorized the exchange offering of three shares of Class C common stock for each share of the Companys outstanding Class B common stock. The Class C common stock was offered on a three-for-one basis to the holders of the Class B common stock. Although having greater voting power, each share of Class C common stock has only one-third of the rights of a share of Class B common stock to dividends and distributions. Class C common stock is convertible into shares of common stock on a three-for-one basis.	'	'	'	'	'
Votes Per Share	'The Class C common stock has 25 votes per share, as compared to 10 votes per share for the Class B common stock and one vote per share for the common stock.	'	'	'	'	'
Class A Non Voting Preferred Stock	'	'	'	'	'	'
Dividends Payable Nature	'On April 3, 1995, the stockholders ratified a proposal consisting of the creation of a new class of Class A non-voting preferred stock with special dividend rights and the declaration of a stock dividend on the Companys common stock consisting of one share of Class A non-voting preferred stock for every five shares of common stock. The stock dividend was payable to holders of common stock on October 20, 1995. The Class A non-voting preferred stock is entitled to a special dividend equal to 3-1/4% of first $10 million, 4-1/2% of next $20 million and 5-1/2% on amounts in excess of $30 million of the amount of any cash awards or settlements received by the Company in connection with the enforcement of five of the Companys patents in its patent lawsuits, less the revised special dividend payable on the common stock with respect to one of the Companys patents. The Class A non-voting preferred stock participates on an equal per share basis with the common stock in any dividends declared and ranks equally with the common stock on distribution rights, liquidation rights and other rights and preferences (other than the voting rights).	'	'	'	'	'
Shares Outstanding	'Class A non-voting preferred stock issued pursuant to such stock dividend approximates 313,000 shares.	'	'	'	'	'
Votes Per Share	'The Class A non-voting preferred stock has no voting rights.	'	'	'	'	'

NOTE_9_CONTROLLING_AND_NONCONT7

NOTE 9 - CONTROLLING AND NONCONTROLLING INTERESTS - (Details Narrative) (USD $)

30 Months Ended

60 Months Ended

12 Months Ended

Jun. 30, 2014

Sep. 01, 2018

1-May-14

Jun. 30, 2013

1-May-13

Feb. 13, 2013

2-May-11

Jan. 01, 2011

1-May-10

Feb. 13, 2013

Jun. 30, 2014

Mar. 05, 2013

Installments

Class A Member

Class B Member

Private Placement

Health Diagnostics Management LLC (HDM)

HDM Equity

MRICenter

Controlling Interest acquired by Company of Health Diagnostics Management, LLC, (HDM)

50.50%

Health Diagnostics Management (HDM) Class A Members ownership interest

49.50%

Health Diagnostics Management (HDM) Class B Members ownership interest

50.50%

Health Diagnostics Management (HDM) Class A (Outside Investors) Members contribution

$19,800,000

Health Diagnostics Management (HDM) Class B (Company) Members contribution

20,200,000

Total Capital Contribution

14,000,000

Bank Term loan

11,000,000

Interest Rate of Term Loan

4.75%

Number of Consecutive Installments

Bank Revolving Credit Loan

3,000,000

Interest Rate of Revolving Credit Loan

4.00%

Health Diagnostics Management (HDM) purchase of Stand-Up MRI Centers from Health Diagnostics, LLC (HD)

Health Diagnostics Management (HDM) purchase of Other MRI Centers from Health Diagnostics, LLC (HD)

Total Cost of Health Diagnostics Management (HDM) purchase of the MRI Centers from Health Diagnostics, LLC (HD)

35,900,000

Consideration to Outside Investors Regarding Health Diagnostics Management (HDM) purchase of the MRI Centers from Health Diagnostics, LLC (HD)

1,500,000

Consideration For Non-Competition and Consulting Agreements Regarding Health Diagnostics Management (HDM) purchase of the MRI Centers from Health Diagnostics, LLC (HD)

4,100,000

Cost of Majority Interest for Health Diagnostics Management LLC (HDM)

40,000,000

Private Placement of Equity and Capital Raise (Imperial)

6,000,000

Private Placement Description (Imperial)

'On May 2, 2011, the Company completed a private placement of equity and succeeded in raising $6,000,000. The offering consisted Of Preferred Class A membership interests in a newly formed limited liability company, Imperial Management Services, LLC (Imperial). The Class B membership interests in Imperial, all of which were retained by the Company's subsidiary, HMCA, hold a 75 percent equity interest in Imperial. The Class A membership interests are entitled to receive a dividend of 18 percent per annum of their cash capital contribution of $6,000,000. HMCA contributed all of its assets, together with its liabilities, to Imperial as HMCAs capital contribution. The Imperial operating agreement provides for the Class A members to receive priority distributions until their original capital contributions are returned. Dividends are payable quarterly beginning August 1, 2011. On May 1, 2014 and on May 1, 2013, the Company returned a portion of the Class A Members capital contribution in the amount of $1,125,100 and $1,424,900, respectively. As of June 30, 2014, the Companys subsidiary, HMCA, now owns approximately 91 percent interest in Imperial Management Services.

HMCA ownership percentage of Imperial

91.00%

Redemption of Class A Members Capital Contribution (Imperial)

1,125,100

14,244,900

Purchase of Interest from Unrelated party of Entity that provides management services to a diagnostic center in the NY Metropolitan Area, Percentage Acquired

50.00%

34.80%

15.20%

Purchase of Interest from Unrelated party of Entity that provides management services to a diagnostic center in the NY Metropolitan Area, Note Issued for Purchase

$700,000

$400,000

Description of Controlling interest in an entity which the Company consolidates

'The Company also has a 50% controlling interest in an entity which the Company consolidates, that provides management services to a diagnostic center in the New York Metropolitan area. The center began operations during January 2012. The noncontrolling interest as of June 30, 2014 and 2013 aggregated $531,474 and $559,221, respectively.

NOTE_11_INCOME_TAXES_Details_N

NOTE 11 - INCOME TAXES - (Details Narrative) (USD $)	12 Months Ended
NOTE 11 - INCOME TAXES - (Details Narrative) (USD $)	Jun. 30, 2014	Jun. 30, 2013
Note 11 - Income Taxes - Details Narrative	'	'
Deferred Tax Asset	$5,740,287	'
Deferred Tax Liability	583,990	'
Net Operating Loss (NOL) Carryforwards Available to Offset Future Taxable Income	137,252,000	'
Research and Development Tax Credit Carryforwards	3,742,000	'
Alternate Minimum Tax Credits	578,000	'
NY State Tax Credit Carryforwards	1,133,000	'
Decrease in Valuation Allowance for Deferred Tax Assets	$6,392,000	$5,206,000

NOTE_13_COMMITMENTS_AND_CONTIN4

NOTE 13 - COMMITMENTS AND CONTINGENCIES - (Details Narrative) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Rent Expense	$4,571,000	$4,035,000
Early termination Expense rent	'	690,000
Employer Contributions to 401(k) Plan	'	'
Average Monthly Payment for Stipulation Agreements	19,552	'
Settlement of Case (value)	'	-755,500
Recorded sales tax obligations - principal	2,665,000	'
Recorded sales tax obligations - interest and penalties	2,374,000	'
Recorded provisions for penalties - Department of Labor and Internal Revenue Service regulations concerning the requirements to file Form 5500 to report activity of its 401K Employee Benefit Plan.	250,000	'
Reserve for Self-Funded Health Insurance Program	344,000	'
Stop-Loss Umbrella Policy with 3rd ParyInsurer to Limit Maximum Potential Liability for individual Claims	100,000	'
2000 Employee Stock Purchase Plan	'	'
2000 Employee Stock Purchase Plan (ESPP)	'The stockholders of the Company approved the 2000 Employee Stock Purchase Plan (ESPP) at the Companys annual stockholders meeting in April 2000. The ESPP provides for eligible employees to acquire common stock of the Company at a discount, not to exceed 15%. This plan has not been put into effect as of June 30, 2014.	'
Golden Triangle	'	'
Details of Case	'On or about June 30, 2010, one of Fonars customers, Golden Triangle Company, Golden Triangle Company v. Fonar Corporation et al, Plaintiff sought up to $5,000,000. Fonar made a motion to dismiss the complaint, the outcome of which left Plaintiff with only a cause of action for breach of contract. The case was settled in June 2013 for $480,000 in cash and 30,000 shares of Fonars common stock payable in installments. The Company recorded a gain of $755,500 on the statements of income for the year ended June 30, 2013.	'
Settlement of Case (value)	480,000	'
Settlement of Case (shares)	30,000	'
Jack Shapiro	'	'
Details of Case	'Jack Shapiro v. Fonar Corporation, July, 2009 to recover $500,000 based on Fonars failure to refund a deposit on an MRI scanner and termination of plaintiffs sales representative agreement. During the year ended June 30, 2013 the case has been settled for $323,000 payable in installments, subject to the plaintiff obtaining a sale for Fonar and the payment of installments of the purchase price by the customer.	'
Settlement of Case (value)	323,000	'
Matt Malek Madison	'	'
Details of Case	'Matt Malek Madison v. Fonar Corporation, August 27, 2007 to recover a down payment for a scanner in the amount of $300,000, with interest. Fonar answered the complaint and sued the plaintiff for breach of contract in the amount of $450,000. Although the case has been concluded, the plaintiff has not taken any steps to collect the judgment. As of June 30, 2014 and 2013, $300,000 was included in the Companys accrued expenses.	'
Settlement of Case (value)	300,000	'
Bonutti Research and Bolt MRI Technology	'	'
Details of Case	'Bonutti Research v. Fonar Corporation, Bonutti Research filed a patent infringement action in the U.S. District Court for the Eastern District Court of New York, The parties have settled the case for $150,000 payable by Fonar in twelve installments and certain licenses and covenants not to sue. The $150,000 has been recorded in the Companys consolidated statements of income for the year ended June 30, 2014. In Bolt MRI Technologies v. Fonar Corporation, The settlement of the Bonutti case covers this case as well.	'
Settlement of Case (value)	$150,000	'

NOTE_15_SUPPLEMENTAL_CASH_FLOW3

NOTE 15 - SUPPLEMENTAL CASH FLOW INFORMATION - (Details Narrative) (USD $)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Note 15 - Supplemental Cash Flow Information - Details Narrative	'	'
Interest paid	$668,475	$389,907
Income taxes paid	$349,501	$277,000

NOTE_16_DUE_TO_RELATED_MEDICAL1

NOTE 16 - DUE TO RELATED MEDICAL PRACTICES - (Details Narrative) (Tallahassee Scanning Services, PA, USD $)	1 Months Ended
	Jun. 30, 2010	Jun. 30, 2014	Jun. 30, 2013
Tallahassee Scanning Services, PA	'	'	'
Equipment Purchased	$550,000	'	'
interest rate/ annum	10.41%	'	'
monthly payment amount	18,769	'	'
payment period	'3 years	'	'
Payment start date	18-Oct-09	'	'
Unpaid Balance	'	$134,880	$134,880

NOTE_17_SEGMENT_AND_RELATED_IN5

NOTE 17 - SEGMENT AND RELATED INFORMATION - (Details Narrative)	12 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Note 17 - Segment And Related Information - Details Narrative	'	'
Export Sales of Medical Equipment	42.40%	3.80%

NOTE_19_SUBSEQUENT_EVENTS_Deta

NOTE 19 - SUBSEQUENT EVENTS - (Details Narrative) (USD $)	3 Months Ended
NOTE 19 - SUBSEQUENT EVENTS - (Details Narrative) (USD $)	Sep. 29, 2014
Note 19 - Subsequent Events - Details Narrative	'
Common shares issued	5,000
Shares value (USD$)	$53,200